<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immun.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3538282</article-id><article-id pub-id-type="doi">10.3389/fimmu.2012.00405</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Hypothesis and Theory</subject></subj-group></subj-group></article-categories><title-group><article-title>Emerging Trends in the Formation and Function of Tuberculosis Granulomas</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lugo-Villarino</surname><given-names>Geanncarlo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn001">*</xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hudrisier</surname><given-names>D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Benard</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Neyrolles</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn001">*</xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>CNRS, Institut de Pharmacologie et de Biologie Structurale</institution><country>Toulouse, France</country></aff><aff id="aff2"><sup>2</sup><institution>Institut de Pharmacologie et de Biologie Structurale, Universit&#x000e9; de Toulouse, Universit&#x000e9; Paul Sabatier</institution><country>Toulouse, France</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Dov L. Boros, Wayne State University School of Medicine, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Hans Acha-Orbea, Center for Immunity and Infection Lausanne, Switzerland; Jean-louis Mege, Aix Marseille Universit&#x000e9;, France; Jennifer A. Philips, NYU School of Medicine, USA</p></fn><corresp id="fn001">*Correspondence: Geanncarlo Lugo-Villarino and Olivier Neyrolles, CNRS, Institut de Pharmacologie et de Biologie Structurale, 205 Route de Narbonne, F-31077 Toulouse, France. e-mail: <email xlink:type="simple">geanncarlo.lugo@ipbs.fr</email>; <email xlink:type="simple">olivier.neyrolles@ipbs.fr</email></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>Geanncarlo Lugo-Villarino, D. Hudrisier and A. Benard have contributed equally to this work.</p></fn><fn fn-type="other" id="fn003"><p>This article was submitted to Frontiers in Inflammation, a specialty of Frontiers in Immunology.</p></fn></author-notes><pub-date pub-type="epreprint"><day>03</day><month>11</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>07</day><month>1</month><year>2013</year></pub-date><pub-date pub-type="collection"><year>2012</year></pub-date><volume>3</volume><elocation-id>405</elocation-id><history><date date-type="received"><day>05</day><month>10</month><year>2012</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Lugo-Villarino, Hudrisier, Benard and Neyrolles.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.</license-p></license></permissions><abstract><p>The granuloma is an elaborated aggregate of immune cells found in non-infectious as well as infectious diseases. It is a hallmark of tuberculosis (TB). Predominantly thought as a host-driven strategy to constrain the bacilli and prevent dissemination, recent discoveries indicate the granuloma can also be modulated into an efficient tool to promote microbial pathogenesis. The aim of future studies will certainly focus on better characterization of the mechanisms driving the modulation of the granuloma functions. Here, we provide unique perspectives from both the innate and adaptive immune system in the formation and the role of the TB granuloma. As macrophages (M&#x003d5;s) comprise the bulk of granulomas, we highlight the emerging concept of M&#x003d5; polarization and its potential impact in the microbicide response, and other activities, that may ultimately shape the fate of granulomas. Alternatively, we shed light on the ability of B-cells to influence inflammatory status within the granuloma.</p></abstract><kwd-group><kwd>macrophage</kwd><kwd>B-cells</kwd><kwd>mycobacteria</kwd><kwd>tuberculosis</kwd><kwd>granuloma</kwd></kwd-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="125"/><page-count count="9"/><word-count count="8664"/></counts></article-meta></front><body><sec><title>Introduction</title><disp-quote><p>&#x0201c;On the basis of my numerous observations I consider it established that, in all tuberculous affections of man and animals, there occur constantly those bacilli which I have designated tubercle bacilli and which are distinguishable from all other microorganisms by characteristic properties.&#x0201d;</p></disp-quote><p>With those celebrated words in 1882, Koch announced the discovery of the etiological agent of one of the oldest recorded human afflictions (Koch, <xref ref-type="bibr" rid="B56">1982</xref>). The term &#x0201c;tubercle&#x0201d; refers to an original description by Sylvius (in 1650) of the apparent lung nodules characteristic of the &#x0201c;consumption&#x0201d; disease, which became christened as &#x0201c;tuberculosis (TB)&#x0201d; by Schonlein (in 1839) in recognition of its intricate correlation with these structures (Sakula, <xref ref-type="bibr" rid="B104">1982</xref>). Today, these tubercles are known as granulomas, defined as organized immune cell aggregates that form in response to persistent TB infection (Ramakrishnan, <xref ref-type="bibr" rid="B95">2012</xref>). The cellular composition of TB granulomas includes M&#x003d5;s, neutrophils, monocytes, dendritic cells, B- and T-cells, fibroblasts, and epithelial cells (Russell, <xref ref-type="bibr" rid="B101">2007</xref>; Ramakrishnan, <xref ref-type="bibr" rid="B95">2012</xref>). Moreover, TB granulomas are characterized by a high-turnover rate of their M&#x003d5; population and by specialized differentiations taking place in mature M&#x003d5;s such as tightly interdigitated cell membranes that make M&#x003d5;s appear either epithelial (Adams, <xref ref-type="bibr" rid="B2">1974</xref>), fusion into multinucleated giant cells (Helming and Gordon, <xref ref-type="bibr" rid="B45">2007</xref>), or differentiation into foamy cells with a high lipid content (Russell et al., <xref ref-type="bibr" rid="B102">2009</xref>). While granulomas have been studied for about 200&#x02009;years, their role in TB etiology remains unclear. In 1819, La&#x000eb;nnec first proposed granulomas as the cause of TB (Sakula, <xref ref-type="bibr" rid="B104">1982</xref>). Yet, about a century went by before Ghon correlated the presence of a single caseous granuloma in the mid-region of the lung with a corresponding nodal involvement (the Ghon complex) and the pathogen&#x02019;s dissemination, thus serving as a marker for latent TB (Dorhoi et al., <xref ref-type="bibr" rid="B25">2011</xref>). In spite of this, subsequent studies and clinical observations established the granuloma as a host-protective structure that &#x0201c;walls off&#x0201d; Mtb to prevent its dissemination, a notion that still predominates. Seminal studies by Ramakrishnan in zebrafish, however, have now evidenced mycobacteria actually exploit the granuloma into a tool for pathogenesis, suggesting its function can be modulated depending on the disease context (Ramakrishnan, <xref ref-type="bibr" rid="B95">2012</xref>). Considering TB is still one of the leading causes of human death due to a single infectious agent, substantial insights into microbe physiology and host defenses rest in the attempt to better understand the mechanisms governing TB granulomas.</p><p>Here, we will focus exclusively in the role of M&#x003d5; polarization in the formation and function of TB granulomas. Likewise, we will provide a unique perspective on the significance of B-cells, whose immune-modulatory function has long been ignored in TB.</p></sec><sec><title>Macrophage Polarization in TB Granulomas</title><p>M&#x003d5; polarization is broadly classified into M1 and M2 programs (Goerdt and Orfanos, <xref ref-type="bibr" rid="B41">1999</xref>; Gordon, <xref ref-type="bibr" rid="B43">2003</xref>; Mantovani et al., <xref ref-type="bibr" rid="B69">2004</xref>; Martinez et al., <xref ref-type="bibr" rid="B70">2009</xref>). On one hand, the M1 program is a response to type-1 inflammatory conditions (e.g., IFN-&#x003b3;), often associated with intracellular pathogen resistance (Quintana-Murci et al., <xref ref-type="bibr" rid="B93">2007</xref>; Benoit et al., <xref ref-type="bibr" rid="B8">2008</xref>). IFN-&#x003b3; is mainly responsible for the establishment of the M1 program, granting M&#x003d5;s the capacity to kill mycobacteria (Flynn et al., <xref ref-type="bibr" rid="B35">1993</xref>; Ehrt et al., <xref ref-type="bibr" rid="B27">2001</xref>). The production of nitric oxide (NO) in M&#x003d5;s (characteristic in murine models) is arguably one of the most important consequences mediated by IFN-&#x003b3;, as mice deficient for NO production succumb to Mtb infection (Chan et al., <xref ref-type="bibr" rid="B16">1992</xref>). In fact, the enzyme iNOS (inducible NO synthase) required for NO production is a bona fide marker of murine M1 M&#x003d5;s (Xie and Nathan, <xref ref-type="bibr" rid="B123">1993</xref>). Other marker genes, whose expression is induced in M1, include <italic>ido1, ptgs2, il12b/il23a, socs3, marco, cd86, irf3/irf5</italic>, and <italic>stat1/stat5</italic>, among others (Lawrence and Natoli, <xref ref-type="bibr" rid="B62">2011</xref>; Murray and Wynn, <xref ref-type="bibr" rid="B80">2011b</xref>). Collectively, the M1 program is part of the &#x0201c;common host response&#x0201d; against intracellular bacteria that endows M&#x003d5;s with a non-permissible nature (Ehrt et al., <xref ref-type="bibr" rid="B27">2001</xref>; Deretic et al., <xref ref-type="bibr" rid="B23">2004</xref>; Martinez et al., <xref ref-type="bibr" rid="B70">2009</xref>; Cairo et al., <xref ref-type="bibr" rid="B14">2011</xref>; Murray and Wynn, <xref ref-type="bibr" rid="B79">2011a</xref>). On the other hand, the M2 program is dictated by type-2 inflammatory signals (e.g., IL-4, IL-10), enabling M&#x003d5;s to participate in the suppression of inflammation, phagocytosis, tissue remodeling, and repair, among others (Sica et al., <xref ref-type="bibr" rid="B109">2008</xref>; Martinez et al., <xref ref-type="bibr" rid="B70">2009</xref>; Murray and Wynn, <xref ref-type="bibr" rid="B79">2011a</xref>). However, this program also renders M&#x003d5;s poorly microbicidal against intracellular pathogens (Raju et al., <xref ref-type="bibr" rid="B94">2008</xref>; Martinez et al., <xref ref-type="bibr" rid="B70">2009</xref>). This is best illustrated by how the arginine metabolism is used in M2 M&#x003d5;s, which shuts down NO production in favor of tissue reparation (Shearer et al., <xref ref-type="bibr" rid="B108">1997</xref>). Indeed, M2 polarization is accompanied by ARG1 (type-1 arginase) expression that inhibits NO production by outcompeting iNOS to convert arginine into ornithine and urea (Munder et al., <xref ref-type="bibr" rid="B78">1998</xref>; El Kasmi et al., <xref ref-type="bibr" rid="B28">2008</xref>). Along arg1, other M2 marker genes include <italic>fizz1, chi311/chi312/chi313, mrc1, cd36, socs2, il-10, klf4, jmjd3/irf4, ppar&#x003b3;</italic>, and <italic>stat6</italic>, among others (Lawrence and Natoli, <xref ref-type="bibr" rid="B62">2011</xref>; Murray and Wynn, <xref ref-type="bibr" rid="B80">2011b</xref>). Altogether, Mtb might influence the granuloma function by controlling M&#x003d5; polarization, a premise that is presciently in line with the following findings, which for the purpose of conciseness, are mainly based on the use of the iNOS/ARG1 polarization axis.</p><p>The animal models to study TB granulomas are discussed in detail elsewhere (Flynn, <xref ref-type="bibr" rid="B33">2006</xref>). Here, we highlight recent findings in mice and zebrafish documenting the TB granuloma dynamics, supported by studies and clinical observations done in TB patients. It is widely postulated the onset of human pulmonary TB begins when inhaled Mtb is captured by M&#x003d5;s and transported across the alveolar epithelium into the lung tissue. In zebrafish, the subsequent steps leading to a nascent granuloma have been captured in real-time imaging (Davis et al., <xref ref-type="bibr" rid="B21">2002</xref>). While infected M&#x003d5;s undergo apoptosis, they promote the recruitment of phagocytes, which upon arrival, display high motility conducive for scavenging apoptotic cells. The phagocytosis of dead M&#x003d5;s leads to the formation of cell aggregates, fomenting bacterial growth. Subsequent rounds of this cycle promote the formation of a stable granuloma in 3&#x02009;days post-infection (<italic>p.i</italic>.), a process that is dependent on the region of difference-1 (RD1) virulence locus of <italic>M. marinum</italic> and independent of T-cells (Davis et al., <xref ref-type="bibr" rid="B21">2002</xref>; Volkman et al., <xref ref-type="bibr" rid="B116">2004</xref>, <xref ref-type="bibr" rid="B117">2010</xref>; Davis and Ramakrishnan, <xref ref-type="bibr" rid="B22">2009</xref>). It is unclear whether zebrafish M&#x003d5;s undergo polarization. Yet, since most transcription factors governing T-cell polarization are highly conserved in zebrafish (Mitra et al., <xref ref-type="bibr" rid="B73">2010</xref>), along with physiological and pathological responses characteristic of type-1 and type-2 immunity (Aggad et al., <xref ref-type="bibr" rid="B3">2010</xref>; Balla et al., <xref ref-type="bibr" rid="B6">2010</xref>; Holt et al., <xref ref-type="bibr" rid="B48">2011</xref>; Wittamer et al., <xref ref-type="bibr" rid="B120">2011</xref>; Renshaw and Trede, <xref ref-type="bibr" rid="B98">2012</xref>), it seems as a matter of time before M&#x003d5; polarization is identified and characterized in this teleost. By contrast, the early stage of Mtb infection in mice is marked by M1 M&#x003d5; polarization, reminiscent of clinical observations in TB patients (Benoit et al., <xref ref-type="bibr" rid="B8">2008</xref>). In fact, transcriptomic analysis of infected murine M&#x003d5;s revealed the gene modulation provoked by Mtb overlaps with that of IFN-&#x003b3; to establish the M1 program (Ehrt et al., <xref ref-type="bibr" rid="B27">2001</xref>). Type-1 inflammatory signals secreted by infected M&#x003d5;s induce cell recruitment and formation of primary granulomas. Unlike zebrafish, however, granuloma formation in mice takes up to 3&#x02009;weeks when <italic>Mycobacterium</italic> reaches a plateau and coincides with adaptive immunity involvement. For instance, nascent liver granulomas were visualized by intravital microscopy between 2 and 3&#x02009;weeks after <italic>Mycobacterium bovis</italic> Calmette&#x02013;Guerin (BCG) challenge (Egen et al., <xref ref-type="bibr" rid="B26">2011</xref>). In another study, Mtb infection did not change the murine M&#x003d5; population (iNOS<sup>low</sup>ARG1<sup>low</sup>) in bronchoalveolar lavage (BAL) during the first week (Redente et al., <xref ref-type="bibr" rid="B97">2010</xref>). At day 21 <italic>p.i</italic>., however, M1 M&#x003d5;s (iNOS<sup>high</sup>ARG1<sup>low</sup>) dominated in BAL and granulomas, coinciding with a peak of IFN-&#x003b3; in infected lungs (Redente et al., <xref ref-type="bibr" rid="B97">2010</xref>). In humans, although NO production by monocyte-derived M&#x003d5;s remains controversial, both iNOS and NO are detected in granulomas and alleles for NOS2 are associated to TB susceptibility (Nicholson et al., <xref ref-type="bibr" rid="B82">1996</xref>; Facchetti et al., <xref ref-type="bibr" rid="B30">1999</xref>; Choi et al., <xref ref-type="bibr" rid="B18">2002</xref>; Schon et al., <xref ref-type="bibr" rid="B106">2004</xref>; Moller et al., <xref ref-type="bibr" rid="B75">2009</xref>). After 35&#x02013;60&#x02009;days <italic>p.i</italic>., while murine M&#x003d5;s at the granuloma core remained iNOS<sup>high</sup>ARG1<sup>low</sup>, there was a dramatic shift toward the M2 program (iNOS<sup>low</sup>ARG1<sup>high</sup>) in M&#x003d5;s surrounding the core, accompanied by elevated type-2 inflammatory signals (Redente et al., <xref ref-type="bibr" rid="B97">2010</xref>). This is in line with ARG1 detection in human TB granulomas (Pessanha et al., <xref ref-type="bibr" rid="B86">2012</xref>).</p><p>The shift toward M2 M&#x003d5;s during Mtb infection could have deleterious consequences for the granuloma as a host-protective structure (Figure <xref ref-type="fig" rid="F1">1</xref>). First, ARG1 expression in uninfected M&#x003d5;s surrounding the granuloma core suggests the development of an immunosuppressive niche. Indeed, Mtb promotes its survival by inducing ARG1 expression through MyD88-dependent signaling pathways (El Kasmi et al., <xref ref-type="bibr" rid="B28">2008</xref>; Qualls et al., <xref ref-type="bibr" rid="B91">2010</xref>). At the transcriptome level, murine M2 M&#x003d5;s displayed a diminished inflammatory response to Mtb as reflected by a reduced NO production and increased of iron availability, alluding ARG1 might also be implicated in nutrient deprivation mechanisms limiting microbial growth (Forbes and Gros, <xref ref-type="bibr" rid="B36">2001</xref>; Kahnert et al., <xref ref-type="bibr" rid="B54">2006</xref>; Cairo et al., <xref ref-type="bibr" rid="B14">2011</xref>). Furthermore, M1 M&#x003d5;s possess a &#x0201c;fail-safe&#x0201d; system sustaining optimum NO production based on citrulline recycling via argininosuccinate synthase (ASS1), which is absent in M2 M&#x003d5;s (Qualls et al., <xref ref-type="bibr" rid="B92">2012</xref>). Given the restrictive granuloma environment where arginine may be limited, the presence of this fail-safe system may become further accentuated. Second, M2 M&#x003d5;s may represent a transitional state into the formation of &#x0201c;foamy&#x0201d; M&#x003d5;s that are rich in cholesterol, a carbon source for microbial intracellular survival (Pandey and Sassetti, <xref ref-type="bibr" rid="B85">2008</xref>; Peyron et al., <xref ref-type="bibr" rid="B87">2008</xref>; Russell et al., <xref ref-type="bibr" rid="B102">2009</xref>; Griffin et al., <xref ref-type="bibr" rid="B44">2011</xref>). Recently, Mtb lipids were shown to trigger PPAR&#x003b3;, the master regulator of M2 polarization, to increase expression of CD36 and induce foam cell formation (Mahajan et al., <xref ref-type="bibr" rid="B68">2012</xref>). Here, we postulate that factors governing M2 polarization establish additional anti-inflammatory signaling loops, like that of CD36, to increase microbial fitness within granulomas (Kuda et al., <xref ref-type="bibr" rid="B58">2011</xref>). Third, the shift toward M2 M&#x003d5;s may allow Mtb to control the antigen-presentation process to undermine adaptive immunity within granulomas (Benoit et al., <xref ref-type="bibr" rid="B8">2008</xref>). Indeed, TB granulomas display a limited antigen-presentation to evoke significant T-cell responses (Egen et al., <xref ref-type="bibr" rid="B26">2011</xref>). While M&#x003d5; polarization was not addressed in this study, M2 M&#x003d5;s do inhibit the proliferation of CD4 T-cells while fomenting the activity of regulatory T-cells (Schebesch et al., <xref ref-type="bibr" rid="B105">1997</xref>; Curiel et al., <xref ref-type="bibr" rid="B20">2004</xref>; Biswas and Mantovani, <xref ref-type="bibr" rid="B11">2010</xref>). Altogether, the shift toward M2 M&#x003d5;s might also occur in human granulomas and contribute to Mtb pathogenesis given that TB susceptibility is often accompanied by elevated type-2 inflammatory and immunosuppressant signals (Kahnert et al., <xref ref-type="bibr" rid="B54">2006</xref>; Raju et al., <xref ref-type="bibr" rid="B94">2008</xref>; Almeida et al., <xref ref-type="bibr" rid="B4">2009</xref>; Schreiber et al., <xref ref-type="bibr" rid="B107">2009</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>A model illustrating the putative roles of M&#x003d5; polarization and B-cell involvement during the formation and function of TB granulomas</bold>. TB granuloma M&#x003d5;s undergo various specialized transformations: they can look like epithelial characterized by tightly interdigitated cell membranes that link adjacent cells; they can fuse into multinucleated giant cells; or they can differentiate into foamy cells with a high content of intracellular lipids. While none of these specialized transformations in the granuloma M&#x003d5; population are well understood, we propose they might be reflection of the M&#x003d5; polarization status that may render the granuloma structure with a microbicidal capacity (top) or as a tool of pathogenesis (bottom). In the former scenario, the local M&#x003d5; population in lung undergoes a M1 polarization early on during Mtb infection and granuloma formation, distinguished by a cell-surface receptor repertoire responsive to pro-inflammatory signaling (e.g., IFN-&#x003b3;R<sup>high</sup>) and conducive for antigen-presentation (e.g., MHC-II<sup>high</sup>, CD86<sup>high</sup>), while acquiring a microbicidal capacity reflected in the NO production (e.g., <italic>iNOS</italic><sup>high</sup>, ASS1<sup>positive</sup>), among others. These M&#x003d5;s have been noted to be most frequently located in the necrotic center of a mature tuberculous granuloma where apoptotic and necrotic M&#x003d5;s are abundant along with extracellular bacteria. Accompanying the M1 M&#x003d5; polarization is the recruitment of neutrophils and Th1 cells, whose migration and activation status might be influenced by a B-cell involvement likely characterized by a pro-inflammatory phenotype (e.g., IFN-&#x003b3;<sup>high</sup> IL-6<sup>high</sup> IgG<sup>high</sup>). In the latter scenario, we propose a change in the TB granuloma environment during the late stages of Mtb infection, distinguished by the M2 M&#x003d5; polarization driven by the high expression of transcription factors (e.g., PPAR&#x003b3;<sup>high</sup>, STAT6<sup>positive</sup>) antagonistic for type-1 inflammation, and characterized by a cell-surface receptor repertoire promoting tissue repair activities (e.g., IL-4R<sup>high</sup>) and the formation of foamy cells (e.g., CD36<sup>high</sup>), while suppressing the microbicidal functions like NO production (e.g., ARG1<sup>high</sup>), among others. We envision M2 M&#x003d5; polarization might give rise to the formation of foam and multinucleated giant cells, whose presence is noted to be most frequently at the rim and center of mature TB granulomas, and which may favor the intracellular resilience of Mtb. Furthermore, classical M2 M&#x003d5;s have been noted to be most frequently located surrounding the granuloma center and overwhelmingly in the local lung environment. Along with the M2 M&#x003d5; polarization is the inhibition of neutrophil recruitment while enhancing that of T<sub>regs</sub>, activities that might be influenced by a B-cell involvement likely characterized by a anti-inflammatory phenotype (e.g., IL-10<sup>high</sup>, CD1d<sup>positive</sup>).</p></caption><graphic xlink:href="fimmu-03-00405-g001"/></fig><p>In the near future, we envision the role of M&#x003d5; polarization in the granuloma context will be tested directly in different ways. First, we expect further advances in real-time imaging in both zebrafish and mouse models. Highly conserved M&#x003d5; polarization markers are ideal candidates for the development of novel animal reporter lines expressing different fluorochromes to target the different M&#x003d5; subsets. Second, specific gene inactivation of M&#x003d5; polarization markers with the use of morpholinos (in zebrafish), siRNA-based technology, or gene-knockout strategy (including conditional strategies), may be used at different stages of granuloma formation in animal models. The strategies above could be used in combination with global array-based transcriptomics and proteomics approaches in order to assess the granuloma and local lung environment in the presence or absence of M&#x003d5; subsets. Collectively, we expect there would be more future efforts to bridge results obtained in animals into the human context as discussed in the conclusion section.</p></sec><sec><title>A Role for B-Cells in Granulomatous Diseases</title><p>Alterations in the lung environment by Mtb and/or subsequent immune responses likely affect the infection outcome. None of these is more apparent than the type-1 inflammatory storm that is unleashed in murine lungs at 3&#x02009;week <italic>p.i</italic>., when a peak of IFN-&#x003b3;/TNF coincides with CD4<sup>+</sup> T-cell involvement, an event that impacts the organization of nascent granuloma structures. Yet, mice in which CD4<sup>+</sup> T-cells are unable to produce IFN-&#x003b3;/TNF are still resistant to TB, suggesting a complex scenario for protection (Torrado and Cooper, <xref ref-type="bibr" rid="B112">2011</xref>). In this perspective article, we propose that, beside T-cells, B-cells modulate the TB granuloma formation and function through interaction with their cellular components.</p><p>Despite extensive evidence for anti-Mtb antibody production in TB patients (Kunnath-Velayudhan et al., <xref ref-type="bibr" rid="B60">2010</xref>, <xref ref-type="bibr" rid="B59">2012</xref>), and a higher susceptibility of pIgR (IgA receptor)-deficient mice (Tjarnlund et al., <xref ref-type="bibr" rid="B111">2006</xref>), initial studies examining the role of antibodies in TB indicated a modest impact in protective immunity, with benefits limited to passive administration of anti-Mtb antibodies (Glatman-Freedman and Casadevall, <xref ref-type="bibr" rid="B40">1998</xref>; Roy et al., <xref ref-type="bibr" rid="B100">2005</xref>; Abebe and Bjune, <xref ref-type="bibr" rid="B1">2009</xref>). This contributed to the notion B-cells played a minor role in TB immunity, if any. Yet, recent studies now provide compelling reasons to revisit the role of B-cells in TB (Cooper, <xref ref-type="bibr" rid="B19">2009</xref>; Maglione and Chan, <xref ref-type="bibr" rid="B65">2009</xref>; Flynn et al., <xref ref-type="bibr" rid="B34">2011</xref>; Philips and Ernst, <xref ref-type="bibr" rid="B88">2012</xref>). First, B-cells infiltrate the lungs of Mtb-infected mice and humans (Tsai et al., <xref ref-type="bibr" rid="B113">2006</xref>), where they organize in ectopic B-cell follicles at the periphery of granulomas (Gonzalez-Juarrero et al., <xref ref-type="bibr" rid="B42">2001</xref>; Ulrichs et al., <xref ref-type="bibr" rid="B114">2004</xref>; Kahnert et al., <xref ref-type="bibr" rid="B53">2007</xref>; Maglione et al., <xref ref-type="bibr" rid="B67">2007</xref>). These foci are the predominant sites of cellular proliferation in the infected lungs attesting to the importance of B-cells in shaping the local environment during infection (Ulrichs et al., <xref ref-type="bibr" rid="B114">2004</xref>). Moreover, B-cells also infiltrate the granuloma structure, as shown in non-human primates where activated B-cell clusters are found in close contact with T-cells (Phuah et al., <xref ref-type="bibr" rid="B89">2012</xref>), and in the lungs from cattle with natural tuberculosis (Beytut, <xref ref-type="bibr" rid="B10">2011</xref>). Mtb-specific B-cells also exist at local sites of infection in pleural fluids, a strategic place to influence the immunity against Mtb (Feng et al., <xref ref-type="bibr" rid="B31">2011</xref>). Beyond TB, B-cells are well-known cellular components in several other granulomatous diseases (Table <xref ref-type="table" rid="T1">1</xref>). Not only B-cells are present in granuloma but also they could be important for their maturation. This is suggested in pristane induced oil granuloma formation (Chen et al., <xref ref-type="bibr" rid="B17">2010</xref>) and during <italic>Schistosoma japonicum</italic> infection (Ji et al., <xref ref-type="bibr" rid="B51">2008</xref>) where the absence of B-cells results in a marked delay in granuloma formation. In the context of the TB, although granulomas form in the absence of B-cells, their numbers and size remain lower and they hardly become inflammatory (Bosio et al., <xref ref-type="bibr" rid="B13">2000</xref>; Maglione et al., <xref ref-type="bibr" rid="B67">2007</xref>). This could be the result of the well-known ability of B-cells to contribute to the organization of secondary and tertiary lymphoid organs (Moseman et al., <xref ref-type="bibr" rid="B77">2012</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Characteristics of B-cells identified in non-TB granulomatous diseases</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Disease or model</th><th align="left" rowspan="1" colspan="1">Type of B-cells</th><th align="left" rowspan="1" colspan="1">Reported role in disease</th><th align="left" rowspan="1" colspan="1">Specie</th><th align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Wegener&#x02019;s granuloma</td><td align="left" rowspan="1" colspan="1">Undefined</td><td align="left" rowspan="1" colspan="1">Detrimental</td><td align="left" rowspan="1" colspan="1">Humans</td><td align="left" rowspan="1" colspan="1">Voswinkel et al. (<xref ref-type="bibr" rid="B118">2008</xref>), Holle et al. (<xref ref-type="bibr" rid="B47">2012</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sarcoidosis</td><td align="left" rowspan="1" colspan="1">Undefined</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">Humans</td><td align="left" rowspan="1" colspan="1">Fukuda et al. (<xref ref-type="bibr" rid="B37">1997</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Churg&#x02013;Strauss syndrome</td><td align="left" rowspan="1" colspan="1">Undefined</td><td align="left" rowspan="1" colspan="1">Detrimental</td><td align="left" rowspan="1" colspan="1">Humans</td><td align="left" rowspan="1" colspan="1">Donvik and Omdal (<xref ref-type="bibr" rid="B24">2011</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Crohn&#x02019;s disease</td><td align="left" rowspan="1" colspan="1">B1<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">Humans</td><td align="left" rowspan="1" colspan="1">Geboes et al. (<xref ref-type="bibr" rid="B39">1986</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Schistosomiasis</td><td align="left" rowspan="1" colspan="1">Undefined</td><td align="left" rowspan="1" colspan="1">Favor protective Th2 immunity; inhibit T-cell-mediated immunopathology; granuloma formation</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Hernandez et al. (<xref ref-type="bibr" rid="B46">1997</xref>, <xref ref-type="bibr" rid="B46">Ferru</xref>), Jankovic et al. (<xref ref-type="bibr" rid="B50">1998</xref>), Jacobs et al. (<xref ref-type="bibr" rid="B49">1999</xref>), Ji et al. (<xref ref-type="bibr" rid="B51">2008</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Leishmaniasis</td><td align="left" rowspan="1" colspan="1">Include B2<xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref> as well as CD5<sup>+</sup>CD1d<sup>+</sup>IL-10 producing regulatory Breg<xref ref-type="table-fn" rid="tfn3"><sup>c</sup></xref> cells</td><td align="left" rowspan="1" colspan="1">Limits immunopathology; favor protective Th2 immunity; favor granuloma formation</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Smelt et al. (<xref ref-type="bibr" rid="B110">2000</xref>), Ronet et al. (<xref ref-type="bibr" rid="B99">2010</xref>), Moore et al. (<xref ref-type="bibr" rid="B76">2012</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Coccidioidomycosis</td><td align="left" rowspan="1" colspan="1">IL-10 producing B<sub>regs</sub></td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">Humans</td><td align="left" rowspan="1" colspan="1">Li et al. (<xref ref-type="bibr" rid="B63">2005</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Paracoccidiois</td><td align="left" rowspan="1" colspan="1">B1, IL-10 producing B<sub>regs</sub></td><td align="left" rowspan="1" colspan="1">Detrimental</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Popi et al. (<xref ref-type="bibr" rid="B90">2008</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cat-scratch disease</td><td align="left" rowspan="1" colspan="1">IL-10 producing B<sub>regs</sub></td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">Humans</td><td align="left" rowspan="1" colspan="1">Vermi et al. (<xref ref-type="bibr" rid="B115">2006</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pristane induced oil granuloma response</td><td align="left" rowspan="1" colspan="1">Undefined</td><td align="left" rowspan="1" colspan="1">Granuloma formation</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Chen et al. (<xref ref-type="bibr" rid="B17">2010</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><p><italic><sup>a</sup>B1 cells: developmentally defined; innate-like B-cells in the mouse; CD5<sup>+</sup> or CD5<sup>&#x02212;</sup> subpopulation poorly defined in humans</italic>.</p></fn><fn id="tfn2"><p><italic><sup>b</sup>B2 cells: developmentally defined; include &#x0201c;conventional&#x0201d; follicular B-cells as well as &#x0201c;innate-like&#x0201d; marginal zone B-cells</italic>.</p></fn><fn id="tfn3"><p><italic><sup>c</sup>B<sub>regs</sub>: functionally defined; present among various B-cell populations including CD5<sup>+</sup>CD1d<sup>+</sup> B-cells; can produce IL-10</italic>.</p></fn></table-wrap-foot></table-wrap><p>Second, although this is a rare event, occurrence of mycobacterial infections was reported upon rituximab-mediated depletion of B-cells, suggesting a protective role for these lymphocytes (Winthrop et al., <xref ref-type="bibr" rid="B119">2008</xref>; Gea-Banacloche, <xref ref-type="bibr" rid="B38">2010</xref>). However, other granulomatous diseases were successfully treated with rituximab (Donvik and Omdal, <xref ref-type="bibr" rid="B24">2011</xref>; Holle et al., <xref ref-type="bibr" rid="B47">2012</xref>), cautioning B-cells may be detrimental depending on the disease context. Finally, beyond antibody production, B-cells display diverse roles in the immunity against multiple pathogens that could operate during TB. In this regard, <italic>Salmonella</italic> infection, though not occasioning granuloma formation, represents a paradigm for antibody-independent roles of B-cells against an intracellular bacterium with the evidence that B-cells producing IL-10 (B<sub>regs</sub>) impairs the control of natural and vaccine-induced immunity to <italic>Salmonella</italic> (Neves et al., <xref ref-type="bibr" rid="B81">2010</xref>). Since this role cannot simply be recapitulated in animal models lacking B-cells (Mastroeni et al., <xref ref-type="bibr" rid="B71">2000</xref>; Mittrucker et al., <xref ref-type="bibr" rid="B74">2000</xref>), this exemplifies how deletion of the B-cell compartment eclipses specific functions of these cells.</p><p>B-cells express adaptive and innate receptors to recognize pathogens (Blumenthal et al., <xref ref-type="bibr" rid="B12">2009</xref>; Rawlings et al., <xref ref-type="bibr" rid="B96">2012</xref>). Beyond antibody production, B-cells secrete various signals including cytokines, and serve as antigen-presenting cells (Rawlings et al., <xref ref-type="bibr" rid="B96">2012</xref>). These immune-modulatory functions are performed by different B-cell subsets depending on their differentiation program (e.g., B1, B2), activation status (e.g., na&#x000ef;ve, effector, memory), tissue distribution, the timing of the immune response, or disease context. From this perspective, the identity of B-cells infiltrating the lungs of TB patients or animals remains relatively unknown. In most cases, these cells (likely B2-cells) have undergone class switch recombination and produce antibodies (Phuah et al., <xref ref-type="bibr" rid="B89">2012</xref>). However, CD5<sup>+</sup>CD1d<sup>+</sup> B1-cells are also observed predominantly in TB patients (Zhang et al., <xref ref-type="bibr" rid="B125">2012</xref>) and in mouse models of TB and other granulomatous diseases (Li et al., <xref ref-type="bibr" rid="B63">2005</xref>; Popi et al., <xref ref-type="bibr" rid="B90">2008</xref>; Ronet et al., <xref ref-type="bibr" rid="B99">2010</xref>). Regardless of their identity or individual contribution, we estimate the B-cell compartment influences the TB granuloma formation and function through interaction with M&#x003d5;s, T-cells, and neutrophils (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><p>As B-cells interact with M&#x003d5;s in TB granulomas (Tsai et al., <xref ref-type="bibr" rid="B113">2006</xref>; Chakravarty et al., <xref ref-type="bibr" rid="B15">2008</xref>), they might affect M&#x003d5; polarization within these structures. A case in point, B1-cells differentiate M2 M&#x003d5;s via IL-10 <italic>in vitro</italic> and in a tumor model (Wong et al., <xref ref-type="bibr" rid="B122">2010</xref>). However, mice deficient for B1-cells (xid model) displayed rather a susceptibility to mycobacterial infection, accompanied by increased levels of IL-10 (Junqueira-Kipnis et al., <xref ref-type="bibr" rid="B52">2005</xref>; Russo and Mariano, <xref ref-type="bibr" rid="B103">2010</xref>). Certainly, there are other B-cell subsets that could compensate as the <italic>in vivo</italic> source of IL-10, like B<sub>regs</sub> (O&#x02019;Garra et al., <xref ref-type="bibr" rid="B83">1990</xref>; Lampropoulou et al., <xref ref-type="bibr" rid="B61">2008</xref>). Likewise, there exist alternative <italic>in vivo</italic> immunosuppressive mechanisms driven by B-cells other than the B1-cell subset, as demonstrated for IgG production favoring FcR-mediated M2 M&#x003d5; polarization in a carcinoma model (Andreu et al., <xref ref-type="bibr" rid="B5">2010</xref>). In line with this observation, FC&#x003b3;RIIB-deficient M&#x003d5;s displayed a M1 M&#x003d5; phenotype upon Mtb infection, express less IL-10 and better control the infection (Maglione et al., <xref ref-type="bibr" rid="B66">2008</xref>). Since the phenotype manifests after 3&#x02009;weeks of infection, IgG-producing B2-cells produced during the course of the adaptive immune response might be involved. B1 cells might rather contribute to M2 polarization through Fc&#x003b3;R-independent IL-10-dependant mechanisms. Whether these events occur within the granuloma is currently unknown. Collectively, these studies infer a B-cell contribution to an immunosuppressive niche within TB granulomas by tilting M&#x003d5;s toward the M2 program.</p><p>If M&#x003d5;s are the main components in nascent TB granulomas, then CD4<sup>+</sup> T-cells are perhaps the most critical component of stable TB granulomas as shown by the re-awakening of latent TB in HIV-1 co-infected patients. In recent years, multiple studies suggest an immune-modulatory role for B-cells in T-cell activity at the granuloma level. On one hand, B-cells can co-localize with T-cells in TB granulomas (Ulrichs et al., <xref ref-type="bibr" rid="B114">2004</xref>; Beytut, <xref ref-type="bibr" rid="B10">2011</xref>), and directly interact with them in the granulomas caused by <italic>Leishmania</italic> (Moore et al., <xref ref-type="bibr" rid="B76">2012</xref>). On the other hand, B-cells influence T-cell effector functions either through cytokine production or antigen-presentation (Lund and Randall, <xref ref-type="bibr" rid="B64">2010</xref>). In TB context, IL-10 derived from B1-cells controls the homeostasis of T-helper-17 (Th17), essential for anti-microbial immunity at epithelial/mucosal barriers (Zhang et al., <xref ref-type="bibr" rid="B125">2012</xref>). Reciprocally, Th-17-associated cytokines promote the formation of B-cell foci in Mtb-infected mice, and correlate with B-cell infiltration in TB patients (Khader et al., <xref ref-type="bibr" rid="B55">2011</xref>; Zhang et al., <xref ref-type="bibr" rid="B124">2011</xref>). In the mouse model, IL-17A (Okamoto Yoshida et al., <xref ref-type="bibr" rid="B84">2010</xref>) or IL-23-deficient (Khader et al., <xref ref-type="bibr" rid="B55">2011</xref>; Zhang et al., <xref ref-type="bibr" rid="B124">2011</xref>) animals have marked defects in the formation of granulomas and/or B-cell follicles. In addition IL-23-deficient mice also have poor levels of IL-17 and IL-22. These deficiencies resulted in a marked alteration of CXCL13 production, the chemokine responsible for B-cell recruitment and follicle formation (Khader et al., <xref ref-type="bibr" rid="B55">2011</xref>; Zhang et al., <xref ref-type="bibr" rid="B124">2011</xref>). It is not known if IL-10 production by B-cells is at the initiation or a secondary consequence of the alterations in IL-17 levels. These observations might provide an explanation for the links reported in TB patients between Th17 and formation of B-cell foci and IL-10 (Zhang et al., <xref ref-type="bibr" rid="B124">2011</xref>, <xref ref-type="bibr" rid="B125">2012</xref>).</p><p>Evidence obtained in non-TB diseases argue B-cells favor Th1 polarization (involved in TB protective immunity) through IL-6 and IFN-&#x003b3; production during <italic>Salmonella</italic> infection, or promote Th2 differentiation (thought to be detrimental during TB) through either IL-2 (Wojciechowski et al., <xref ref-type="bibr" rid="B121">2009</xref>) or IL-10 (Ferru et al., <xref ref-type="bibr" rid="B32">1998</xref>; Popi et al., <xref ref-type="bibr" rid="B90">2008</xref>; Ronet et al., <xref ref-type="bibr" rid="B99">2010</xref>) in the control of different parasites. Conversely, B-cells also suppress T-cell activity as best illustrated in mice with a targeted deletion of MyD88 in B-cells during <italic>Salmonella</italic> infection (Neves et al., <xref ref-type="bibr" rid="B81">2010</xref>). Finally, evidencing the role of B-cells as antigen-presenting cells, mice with a targeted deletion of MHC-II in B-cells displayed a reduction of IL-2 and IFN-&#x003b3; by CD4<sup>+</sup> memory T-cells during <italic>Salmonella</italic> challenge (Barr et al., <xref ref-type="bibr" rid="B7">2010</xref>), and low pulmonary Th1 cell counts during <italic>Pneumocystis</italic> infection (Lund and Randall, <xref ref-type="bibr" rid="B64">2010</xref>).</p><p>Another cell influencing TB granuloma formation is the neutrophil, whose migration can be controlled by B-cells. During <italic>Salmonella</italic> infection, mice with a targeted deletion of MyD88 in B-cells exhibited an accumulation of neutrophils in the spleen, an effect that likely depends on B<sub>regs</sub>-mediated IL-10 production (Neves et al., <xref ref-type="bibr" rid="B81">2010</xref>). In the context of mycobacterial infections, aberrant neutrophil migration is known to have deleterious effects in host tissue integrity (Eruslanov et al., <xref ref-type="bibr" rid="B29">2005</xref>; Berry et al., <xref ref-type="bibr" rid="B9">2010</xref>). In mice deficient for the B-cell compartment (Maglione et al., <xref ref-type="bibr" rid="B67">2007</xref>), Mtb infection leads to an uncontrolled accumulation of pulmonary neutrophils, an observation also supported by the excessive neutrophil migration in the peritoneum after BCG-vaccination (Kondratieva et al., <xref ref-type="bibr" rid="B57">2010</xref>). These examples highlight the importance of tolerance mechanisms in TB.</p><p>Based on the above observation, it is tempting to propose that B-cell could act at different levels during TB such as during granuloma progression and by influencing the effector function of third-party cells like M&#x003d5;s. To directly examine this, studying B-cell contribution through comparison of B-cell-competent vs. B-cell-deficient animals should now be further complemented by studies examining the direct response of B-cells to Mtb infection, and through analyses in animal models lacking specific pathways in B-cells and biological consequences.</p></sec><sec><title>Conclusion</title><p>Among trends emerging in TB etiology, the notion that the local lung environment shifts from a host-protective nature toward one favorable to microbial resilience is discussed here at the granuloma level and in the context of M&#x003d5; polarization and B-cell function (see also an illustration in Figure <xref ref-type="fig" rid="F1">1</xref>). Exploring these issues will likely bring us closer to uncover the enigma concealed by TB granulomas. One can envisage that studies investigating the role of genes involved in host tolerance (Medzhitov et al., <xref ref-type="bibr" rid="B72">2012</xref>) might be a good way to explore these aspects of the disease. Although in humans this could be limited to immunogenetic studies, more mechanistic studies could be conducted in animal models where selective inactivation of those genes could provide new insights on the consequences on the pathology. These studies could go along with more sophisticated approaches based on single cell analysis such as those involving laser microdissection or more global phenotypic signatures obtained from mass cytometry, in order to further identify cell subsets involved at different stages of granuloma formation and TB.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The authors received no specific funding for this work. The Neyrolles laboratory is supported by the CNRS, the European Union (7th Framework Programme and ERA-NET), <italic>Agence Nationale de la Recherche, Fondation pour la Recherche M&#x000e9;dicale</italic> (FRM), and <italic>Fondation M&#x000e9;rieux</italic>. Geanncarlo Lugo-Villarino and A. Benard are supported by fellowships from FRM.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abebe</surname><given-names>F.</given-names></name><name><surname>Bjune</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>The protective role of antibody responses during Mycobacterium tuberculosis infection</article-title>. <source>Clin. Exp. Immunol.</source><volume>157</volume>, <fpage>235</fpage>&#x02013;<lpage>243</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2009.03967.x</pub-id><pub-id pub-id-type="pmid">19604263</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>D. O.</given-names></name></person-group> (<year>1974</year>). <article-title>The structure of mononuclear phagocytes differentiating in vivo. I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG)</article-title>. <source>Am. J. Pathol.</source>
<volume>76</volume>, <fpage>17</fpage>&#x02013;<lpage>48</lpage><pub-id pub-id-type="pmid">4601921</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggad</surname><given-names>D.</given-names></name><name><surname>Stein</surname><given-names>C.</given-names></name><name><surname>Sieger</surname><given-names>D.</given-names></name><name><surname>Mazel</surname><given-names>M.</given-names></name><name><surname>Boudinot</surname><given-names>P.</given-names></name><name><surname>Herbomel</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>In vivo analysis of Ifn-gamma1 and Ifn-gamma2 signaling in zebrafish</article-title>. <source>J. Immunol.</source>
<volume>185</volume>, <fpage>6774</fpage>&#x02013;<lpage>6782</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000549</pub-id><pub-id pub-id-type="pmid">21048110</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>A. S.</given-names></name><name><surname>Lago</surname><given-names>P. M.</given-names></name><name><surname>Boechat</surname><given-names>N.</given-names></name><name><surname>Huard</surname><given-names>R. C.</given-names></name><name><surname>Lazzarini</surname><given-names>L. C.</given-names></name><name><surname>Santos</surname><given-names>A. R.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity</article-title>. <source>J. Immunol.</source>
<volume>183</volume>, <fpage>718</fpage>&#x02013;<lpage>731</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0801212</pub-id><pub-id pub-id-type="pmid">19535630</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreu</surname><given-names>P.</given-names></name><name><surname>Johansson</surname><given-names>M.</given-names></name><name><surname>Affara</surname><given-names>N. I.</given-names></name><name><surname>Pucci</surname><given-names>F.</given-names></name><name><surname>Tan</surname><given-names>T.</given-names></name><name><surname>Junankar</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>FcRgamma activation regulates inflammation-associated squamous carcinogenesis</article-title>. <source>Cancer Cell</source>
<volume>17</volume>, <fpage>121</fpage>&#x02013;<lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2009.12.019</pub-id><pub-id pub-id-type="pmid">20138013</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balla</surname><given-names>K. M.</given-names></name><name><surname>Lugo-Villarino</surname><given-names>G.</given-names></name><name><surname>Spitsbergen</surname><given-names>J. M.</given-names></name><name><surname>Stachura</surname><given-names>D. L.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Banuelos</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants</article-title>. <source>Blood</source>
<volume>116</volume>, <fpage>3944</fpage>&#x02013;<lpage>3954</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-03-267419</pub-id><pub-id pub-id-type="pmid">20713961</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>T. A.</given-names></name><name><surname>Brown</surname><given-names>S.</given-names></name><name><surname>Mastroeni</surname><given-names>P.</given-names></name><name><surname>Gray</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica</article-title>. <source>J. Immunol.</source>
<volume>185</volume>, <fpage>2783</fpage>&#x02013;<lpage>2789</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1001431</pub-id><pub-id pub-id-type="pmid">20675594</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>M.</given-names></name><name><surname>Desnues</surname><given-names>B.</given-names></name><name><surname>Mege</surname><given-names>J. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Macrophage polarization in bacterial infections</article-title>. <source>J. Immunol.</source>
<volume>181</volume>, <fpage>3733</fpage>&#x02013;<lpage>3739</lpage><pub-id pub-id-type="pmid">18768823</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>M. P.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Bloch</surname><given-names>S. A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source>
<volume>466</volume>, <fpage>973</fpage>&#x02013;<lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beytut</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Immunohistochemical evaluation of surfactant proteins and lymphocyte phenotypes in the lungs of cattle with natural tuberculosis</article-title>. <source>Res. Vet. Sci.</source>
<volume>91</volume>, <fpage>119</fpage>&#x02013;<lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.rvsc.2010.07.023</pub-id><pub-id pub-id-type="pmid">20800246</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>S. K.</given-names></name><name><surname>Mantovani</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm</article-title>. <source>Nat. Immunol.</source>
<volume>11</volume>, <fpage>889</fpage>&#x02013;<lpage>896</lpage><pub-id pub-id-type="doi">10.1038/ni.1937</pub-id><pub-id pub-id-type="pmid">20856220</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>A.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Pierini</surname><given-names>L. M.</given-names></name><name><surname>Banaei</surname><given-names>N.</given-names></name><name><surname>Ernst</surname><given-names>J. D.</given-names></name><name><surname>Miyake</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins</article-title>. <source>Cell Host Microbe</source>
<volume>5</volume>, <fpage>35</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2008.12.002</pub-id><pub-id pub-id-type="pmid">19154986</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosio</surname><given-names>C. M.</given-names></name><name><surname>Gardner</surname><given-names>D.</given-names></name><name><surname>Elkins</surname><given-names>K. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology</article-title>. <source>J. Immunol.</source>
<volume>164</volume>, <fpage>6417</fpage>&#x02013;<lpage>6425</lpage><pub-id pub-id-type="pmid">10843697</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cairo</surname><given-names>G.</given-names></name><name><surname>Recalcati</surname><given-names>S.</given-names></name><name><surname>Mantovani</surname><given-names>A.</given-names></name><name><surname>Locati</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype</article-title>. <source>Trends Immunol.</source>
<volume>32</volume>, <fpage>241</fpage>&#x02013;<lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.it.2011.03.007</pub-id><pub-id pub-id-type="pmid">21514223</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarty</surname><given-names>S. D.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Tsai</surname><given-names>M. C.</given-names></name><name><surname>Mohan</surname><given-names>V. P.</given-names></name><name><surname>Marino</surname><given-names>S.</given-names></name><name><surname>Kirschner</surname><given-names>D. E.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs</article-title>. <source>Infect. Immun.</source>
<volume>76</volume>, <fpage>916</fpage>&#x02013;<lpage>926</lpage><pub-id pub-id-type="doi">10.1128/IAI.01011-07</pub-id><pub-id pub-id-type="pmid">18212087</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Magliozzo</surname><given-names>R. S.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group> (<year>1992</year>). <article-title>Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages</article-title>. <source>J. Exp. Med.</source>
<volume>175</volume>, <fpage>1111</fpage>&#x02013;<lpage>1122</lpage><pub-id pub-id-type="doi">10.1084/jem.175.4.1111</pub-id><pub-id pub-id-type="pmid">1552282</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Liao</surname><given-names>D.</given-names></name><name><surname>Holl</surname><given-names>T. M.</given-names></name><name><surname>Snowden</surname><given-names>P.</given-names></name><name><surname>Ueda</surname><given-names>Y.</given-names></name><name><surname>Kelsoe</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic regulation of pristane-induced oil granuloma responses</article-title>. <source>Int. J. Exp. Pathol.</source>
<volume>91</volume>, <fpage>472</fpage>&#x02013;<lpage>483</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2613.2010.00725.x</pub-id><pub-id pub-id-type="pmid">20804539</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H. S.</given-names></name><name><surname>Rai</surname><given-names>P. R.</given-names></name><name><surname>Chu</surname><given-names>H. W.</given-names></name><name><surname>Cool</surname><given-names>C.</given-names></name><name><surname>Chan</surname><given-names>E. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis</article-title>. <source>Am. J. Respir. Crit. Care Med.</source>
<volume>166</volume>, <fpage>178</fpage>&#x02013;<lpage>186</lpage><pub-id pub-id-type="doi">10.1164/rccm.2201023</pub-id><pub-id pub-id-type="pmid">12119230</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Cell-mediated immune responses in tuberculosis</article-title>. <source>Annu. Rev. Immunol.</source>
<volume>27</volume>, <fpage>393</fpage>&#x02013;<lpage>422</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132703</pub-id><pub-id pub-id-type="pmid">19302046</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curiel</surname><given-names>T. J.</given-names></name><name><surname>Coukos</surname><given-names>G.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name><name><surname>Alvarez</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>P.</given-names></name><name><surname>Mottram</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival</article-title>. <source>Nat. Med.</source>
<volume>10</volume>, <fpage>942</fpage>&#x02013;<lpage>949</lpage><pub-id pub-id-type="doi">10.1038/nm1093</pub-id><pub-id pub-id-type="pmid">15322536</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Clay</surname><given-names>H.</given-names></name><name><surname>Lewis</surname><given-names>J. L.</given-names></name><name><surname>Ghori</surname><given-names>N.</given-names></name><name><surname>Herbomel</surname><given-names>P.</given-names></name><name><surname>Ramakrishnan</surname><given-names>L.</given-names></name></person-group> (<year>2002</year>). <article-title>Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos</article-title>. <source>Immunity</source>
<volume>17</volume>, <fpage>693</fpage>&#x02013;<lpage>702</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00475-2</pub-id><pub-id pub-id-type="pmid">12479816</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Ramakrishnan</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>The role of the granuloma in expansion and dissemination of early tuberculous infection</article-title>. <source>Cell</source>
<volume>136</volume>, <fpage>37</fpage>&#x02013;<lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.11.014</pub-id><pub-id pub-id-type="pmid">19135887</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deretic</surname><given-names>V.</given-names></name><name><surname>Vergne</surname><given-names>I.</given-names></name><name><surname>Chua</surname><given-names>J.</given-names></name><name><surname>Master</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>S. B.</given-names></name><name><surname>Fazio</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Endosomal membrane traffic: convergence point targeted by Mycobacterium tuberculosis and HIV</article-title>. <source>Cell. Microbiol.</source>
<volume>6</volume>, <fpage>999</fpage>&#x02013;<lpage>1009</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2004.00449.x</pub-id><pub-id pub-id-type="pmid">15469429</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donvik</surname><given-names>K. K.</given-names></name><name><surname>Omdal</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Churg-Strauss syndrome successfully treated with rituximab</article-title>. <source>Rheumatol. Int.</source>
<volume>31</volume>, <fpage>89</fpage>&#x02013;<lpage>91</lpage><pub-id pub-id-type="doi">10.1007/s00296-009-1146-6</pub-id><pub-id pub-id-type="pmid">19789874</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A.</given-names></name><name><surname>Reece</surname><given-names>S. T.</given-names></name><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name></person-group> (<year>2011</year>). <article-title>For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection</article-title>. <source>Immunol. Rev.</source>
<volume>240</volume>, <fpage>235</fpage>&#x02013;<lpage>251</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2010.00994.x</pub-id><pub-id pub-id-type="pmid">21349097</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egen</surname><given-names>J. G.</given-names></name><name><surname>Rothfuchs</surname><given-names>A. G.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name><name><surname>Horwitz</surname><given-names>M. A.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Germain</surname><given-names>R. N.</given-names></name></person-group> (<year>2011</year>). <article-title>Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas</article-title>. <source>Immunity</source>
<volume>34</volume>, <fpage>807</fpage>&#x02013;<lpage>819</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.03.022</pub-id><pub-id pub-id-type="pmid">21596592</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrt</surname><given-names>S.</given-names></name><name><surname>Schnappinger</surname><given-names>D.</given-names></name><name><surname>Bekiranov</surname><given-names>S.</given-names></name><name><surname>Drenkow</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>S.</given-names></name><name><surname>Gingeras</surname><given-names>T. R.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase</article-title>. <source>J. Exp. Med.</source>
<volume>194</volume>, <fpage>1123</fpage>&#x02013;<lpage>1140</lpage><pub-id pub-id-type="doi">10.1084/jem.194.8.1123</pub-id><pub-id pub-id-type="pmid">11602641</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Kasmi</surname><given-names>K. C.</given-names></name><name><surname>Qualls</surname><given-names>J. E.</given-names></name><name><surname>Pesce</surname><given-names>J. T.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name><name><surname>Thompson</surname><given-names>R. W.</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens</article-title>. <source>Nat. Immunol.</source>
<volume>9</volume>, <fpage>1399</fpage>&#x02013;<lpage>1406</lpage><pub-id pub-id-type="doi">10.1038/ni.1671</pub-id><pub-id pub-id-type="pmid">18978793</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eruslanov</surname><given-names>E. B.</given-names></name><name><surname>Lyadova</surname><given-names>I. V.</given-names></name><name><surname>Kondratieva</surname><given-names>T. K.</given-names></name><name><surname>Majorov</surname><given-names>K. B.</given-names></name><name><surname>Scheglov</surname><given-names>I. V.</given-names></name><name><surname>Orlova</surname><given-names>M. O.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice</article-title>. <source>Infect. Immun.</source>
<volume>73</volume>, <fpage>1744</fpage>&#x02013;<lpage>1753</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.3.1744-1753.2005</pub-id><pub-id pub-id-type="pmid">15731075</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facchetti</surname><given-names>F.</given-names></name><name><surname>Vermi</surname><given-names>W.</given-names></name><name><surname>Fiorentini</surname><given-names>S.</given-names></name><name><surname>Chilosi</surname><given-names>M.</given-names></name><name><surname>Caruso</surname><given-names>A.</given-names></name><name><surname>Duse</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions</article-title>. <source>Am. J. Pathol.</source>
<volume>154</volume>, <fpage>145</fpage>&#x02013;<lpage>152</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)65261-3</pub-id><pub-id pub-id-type="pmid">9916929</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Qiao</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Fu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>B lymphocytes that migrate to tuberculous pleural fluid via the SDF-1/CXCR4 axis actively respond to antigens specific for Mycobacterium tuberculosis</article-title>. <source>Eur. J. Immunol.</source>
<volume>41</volume>, <fpage>3261</fpage>&#x02013;<lpage>3269</lpage><pub-id pub-id-type="doi">10.1002/eji.201141625</pub-id><pub-id pub-id-type="pmid">21818756</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferru</surname><given-names>I.</given-names></name><name><surname>Roye</surname><given-names>O.</given-names></name><name><surname>Delacre</surname><given-names>M.</given-names></name><name><surname>Auriault</surname><given-names>C.</given-names></name><name><surname>Wolowczuk</surname><given-names>I.</given-names></name></person-group> (<year>1998</year>). <article-title>Infection of B-cell-deficient mice by the parasite Schistosoma mansoni: demonstration of the participation of B cells in granuloma modulation</article-title>. <source>Scand. J. Immunol.</source>
<volume>48</volume>, <fpage>233</fpage>&#x02013;<lpage>240</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3083.1998.00376.x</pub-id><pub-id pub-id-type="pmid">9743206</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Lessons from experimental Mycobacterium tuberculosis infections</article-title>. <source>Microbes Infect.</source>
<volume>8</volume>, <fpage>1179</fpage>&#x02013;<lpage>1188</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2005.10.033</pub-id><pub-id pub-id-type="pmid">16513383</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>P. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Macrophages and control of granulomatous inflammation in tuberculosis</article-title>. <source>Mucosal Immunol.</source>
<volume>4</volume>, <fpage>271</fpage>&#x02013;<lpage>278</lpage><pub-id pub-id-type="doi">10.1038/mi.2011.14</pub-id><pub-id pub-id-type="pmid">21430653</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Triebold</surname><given-names>K. J.</given-names></name><name><surname>Dalton</surname><given-names>D. K.</given-names></name><name><surname>Stewart</surname><given-names>T. A.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group> (<year>1993</year>). <article-title>An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection</article-title>. <source>J. Exp. Med.</source>
<volume>178</volume>, <fpage>2249</fpage>&#x02013;<lpage>2254</lpage><pub-id pub-id-type="doi">10.1084/jem.178.6.2249</pub-id><pub-id pub-id-type="pmid">7504064</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forbes</surname><given-names>J. R.</given-names></name><name><surname>Gros</surname><given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions</article-title>. <source>Trends Microbiol.</source>
<volume>9</volume>, <fpage>397</fpage>&#x02013;<lpage>403</lpage><pub-id pub-id-type="doi">10.1016/S0966-842X(01)02098-4</pub-id><pub-id pub-id-type="pmid">11514223</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>T.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name><name><surname>Tachikawa</surname><given-names>S.</given-names></name><name><surname>Ohnuki</surname><given-names>K.</given-names></name><name><surname>Ohtani</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name></person-group> (<year>1997</year>). <article-title>Mucosa-associated lymphoid tissue lymphoma coexisting with epithelioid granulomas in the stomach of a patient with systemic sarcoidosis</article-title>. <source>Pathol. Int.</source>
<volume>47</volume>, <fpage>870</fpage>&#x02013;<lpage>875</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1827.1997.tb04533.x</pub-id><pub-id pub-id-type="pmid">9503470</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gea-Banacloche</surname><given-names>J. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Rituximab-associated infections</article-title>. <source>Semin. Hematol.</source>
<volume>47</volume>, <fpage>187</fpage>&#x02013;<lpage>198</lpage><pub-id pub-id-type="doi">10.1053/j.seminhematol.2010.01.002</pub-id><pub-id pub-id-type="pmid">20350666</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geboes</surname><given-names>K.</given-names></name><name><surname>Van Den Oord</surname><given-names>J.</given-names></name><name><surname>De Wolf-Peeters</surname><given-names>C.</given-names></name><name><surname>Desmet</surname><given-names>V.</given-names></name><name><surname>Rutgeerts</surname><given-names>P.</given-names></name><name><surname>Janssens</surname><given-names>J.</given-names></name><etal/></person-group> (<year>1986</year>). <article-title>The cellular composition of granulomas in mesenteric lymph nodes from patients with Crohn&#x02019;s disease</article-title>. <source>Virchows Arch. A Pathol. Anat. Histopathol.</source>
<volume>409</volume>, <fpage>679</fpage>&#x02013;<lpage>692</lpage><pub-id pub-id-type="doi">10.1007/BF00713433</pub-id><pub-id pub-id-type="pmid">3092463</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glatman-Freedman</surname><given-names>A.</given-names></name><name><surname>Casadevall</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis</article-title>. <source>Clin. Microbiol. Rev.</source>
<volume>11</volume>, <fpage>514</fpage>&#x02013;<lpage>532</lpage><pub-id pub-id-type="pmid">9665981</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goerdt</surname><given-names>S.</given-names></name><name><surname>Orfanos</surname><given-names>C. E.</given-names></name></person-group> (<year>1999</year>). <article-title>Other functions, other genes: alternative activation of antigen-presenting cells</article-title>. <source>Immunity</source>
<volume>10</volume>, <fpage>137</fpage>&#x02013;<lpage>142</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80014-X</pub-id><pub-id pub-id-type="pmid">10072066</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Juarrero</surname><given-names>M.</given-names></name><name><surname>Turner</surname><given-names>O. C.</given-names></name><name><surname>Turner</surname><given-names>J.</given-names></name><name><surname>Marietta</surname><given-names>P.</given-names></name><name><surname>Brooks</surname><given-names>J. V.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis</article-title>. <source>Infect. Immun.</source>
<volume>69</volume>, <fpage>1722</fpage>&#x02013;<lpage>1728</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.2.1127-1133.2001</pub-id><pub-id pub-id-type="pmid">11179349</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Alternative activation of macrophages</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>3</volume>, <fpage>23</fpage>&#x02013;<lpage>35</lpage><pub-id pub-id-type="doi">10.1038/nri978</pub-id><pub-id pub-id-type="pmid">12511873</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>J. E.</given-names></name><name><surname>Gawronski</surname><given-names>J. D.</given-names></name><name><surname>Dejesus</surname><given-names>M. A.</given-names></name><name><surname>Ioerger</surname><given-names>T. R.</given-names></name><name><surname>Akerley</surname><given-names>B. J.</given-names></name><name><surname>Sassetti</surname><given-names>C. M.</given-names></name></person-group> (<year>2011</year>). <article-title>High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism</article-title>. <source>PLoS Pathog.</source>
<volume>7</volume>:<fpage>e1002251</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002251</pub-id><pub-id pub-id-type="pmid">21980284</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helming</surname><given-names>L.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>The molecular basis of macrophage fusion</article-title>. <source>Immunobiology</source>
<volume>212</volume>, <fpage>785</fpage>&#x02013;<lpage>793</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2007.09.012</pub-id><pub-id pub-id-type="pmid">18086379</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>H. J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Stadecker</surname><given-names>M. J.</given-names></name></person-group> (<year>1997</year>). <article-title>In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation</article-title>. <source>J. Immunol.</source>
<volume>158</volume>, <fpage>4832</fpage>&#x02013;<lpage>4837</lpage><pub-id pub-id-type="pmid">9144498</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holle</surname><given-names>J. U.</given-names></name><name><surname>Dubrau</surname><given-names>C.</given-names></name><name><surname>Herlyn</surname><given-names>K.</given-names></name><name><surname>Heller</surname><given-names>M.</given-names></name><name><surname>Ambrosch</surname><given-names>P.</given-names></name><name><surname>Noelle</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Rituximab for refractory granulomatosis with polyangiitis (Wegener&#x02019;s granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations</article-title>. <source>Ann. Rheum. Dis.</source>
<volume>71</volume>, <fpage>327</fpage>&#x02013;<lpage>333</lpage><pub-id pub-id-type="doi">10.1136/ard.2011.153601</pub-id><pub-id pub-id-type="pmid">22021864</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>A.</given-names></name><name><surname>Mitra</surname><given-names>S.</given-names></name><name><surname>Van Der Sar</surname><given-names>A. M.</given-names></name><name><surname>Alnabulsi</surname><given-names>A.</given-names></name><name><surname>Secombes</surname><given-names>C. J.</given-names></name><name><surname>Bird</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Discovery of zebrafish (Danio rerio) interleukin-23 alpha (IL-23alpha) chain, a subunit important for the formation of IL-23, a cytokine involved in the development of Th17 cells and inflammation</article-title>. <source>Mol. Immunol.</source>
<volume>48</volume>, <fpage>981</fpage>&#x02013;<lpage>991</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2010.12.012</pub-id><pub-id pub-id-type="pmid">21324528</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>W.</given-names></name><name><surname>Bogers</surname><given-names>J.</given-names></name><name><surname>Van Marck</surname><given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title>Distinct B-cell populations are present in hepatic and intestinal Schistosoma mansoni granulomas</article-title>. <source>Acta Gastroenterol. Belg.</source>
<volume>62</volume>, <fpage>178</fpage>&#x02013;<lpage>181</lpage><pub-id pub-id-type="pmid">10427778</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>D.</given-names></name><name><surname>Cheever</surname><given-names>A. W.</given-names></name><name><surname>Kullberg</surname><given-names>M. C.</given-names></name><name><surname>Wynn</surname><given-names>T. A.</given-names></name><name><surname>Yap</surname><given-names>G.</given-names></name><name><surname>Caspar</surname><given-names>P.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling</article-title>. <source>J. Exp. Med.</source>
<volume>187</volume>, <fpage>619</fpage>&#x02013;<lpage>629</lpage><pub-id pub-id-type="doi">10.1084/jem.187.4.619</pub-id><pub-id pub-id-type="pmid">9463412</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Zuo</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>B cell response is required for granuloma formation in the early infection of Schistosoma japonicum</article-title>. <source>PLoS ONE</source>
<volume>3</volume>:<fpage>e1724</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0001724</pub-id><pub-id pub-id-type="pmid">18320044</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junqueira-Kipnis</surname><given-names>A. P.</given-names></name><name><surname>Kipnis</surname><given-names>A.</given-names></name><name><surname>Henao Tamayo</surname><given-names>M.</given-names></name><name><surname>Harton</surname><given-names>M.</given-names></name><name><surname>Gonzalez Juarrero</surname><given-names>M.</given-names></name><name><surname>Basaraba</surname><given-names>R. J.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis</article-title>. <source>Immunology</source>
<volume>115</volume>, <fpage>246</fpage>&#x02013;<lpage>252</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2005.02136.x</pub-id><pub-id pub-id-type="pmid">15885131</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahnert</surname><given-names>A.</given-names></name><name><surname>Hopken</surname><given-names>U. E.</given-names></name><name><surname>Stein</surname><given-names>M.</given-names></name><name><surname>Bandermann</surname><given-names>S.</given-names></name><name><surname>Lipp</surname><given-names>M.</given-names></name><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs</article-title>. <source>J. Infect. Dis.</source>
<volume>195</volume>, <fpage>46</fpage>&#x02013;<lpage>54</lpage><pub-id pub-id-type="doi">10.1086/508894</pub-id><pub-id pub-id-type="pmid">17152008</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahnert</surname><given-names>A.</given-names></name><name><surname>Seiler</surname><given-names>P.</given-names></name><name><surname>Stein</surname><given-names>M.</given-names></name><name><surname>Bandermann</surname><given-names>S.</given-names></name><name><surname>Hahnke</surname><given-names>K.</given-names></name><name><surname>Mollenkopf</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis</article-title>. <source>Eur. J. Immunol.</source>
<volume>36</volume>, <fpage>631</fpage>&#x02013;<lpage>647</lpage><pub-id pub-id-type="doi">10.1002/eji.200535496</pub-id><pub-id pub-id-type="pmid">16479545</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname><given-names>S. A.</given-names></name><name><surname>Guglani</surname><given-names>L.</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J.</given-names></name><name><surname>Gopal</surname><given-names>R.</given-names></name><name><surname>Junecko</surname><given-names>B. A.</given-names></name><name><surname>Fountain</surname><given-names>J. J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung</article-title>. <source>J. Immunol.</source>
<volume>187</volume>, <fpage>5402</fpage>&#x02013;<lpage>5407</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101377</pub-id><pub-id pub-id-type="pmid">22003199</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>R.</given-names></name></person-group> (<year>1982</year>). <article-title>[The etiology of tuberculosis by Dr. Robert Koch. From the Berliner Klinische Wochenschrift, Volume 19 (1882)]</article-title>. <source>Zentralbl. Bakteriol. Mikrobiol. Hyg. A</source>
<volume>251</volume>, <fpage>287</fpage>&#x02013;<lpage>296</lpage><pub-id pub-id-type="pmid">6805152</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondratieva</surname><given-names>T. K.</given-names></name><name><surname>Rubakova</surname><given-names>E. I.</given-names></name><name><surname>Linge</surname><given-names>I. A.</given-names></name><name><surname>Evstifeev</surname><given-names>V. V.</given-names></name><name><surname>Majorov</surname><given-names>K. B.</given-names></name><name><surname>Apt</surname><given-names>A. S.</given-names></name></person-group> (<year>2010</year>). <article-title>B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guerin vaccination against tuberculosis infection in mice</article-title>. <source>J. Immunol.</source>
<volume>184</volume>, <fpage>1227</fpage>&#x02013;<lpage>1234</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902011</pub-id><pub-id pub-id-type="pmid">20028653</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuda</surname><given-names>O.</given-names></name><name><surname>Jenkins</surname><given-names>C. M.</given-names></name><name><surname>Skinner</surname><given-names>J. R.</given-names></name><name><surname>Moon</surname><given-names>S. H.</given-names></name><name><surname>Su</surname><given-names>X.</given-names></name><name><surname>Gross</surname><given-names>R. W.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>CD36 protein is involved in store-operated calcium flux, phospholipase A2 activation, and production of prostaglandin E2</article-title>. <source>J. Biol. Chem.</source>
<volume>286</volume>, <fpage>17785</fpage>&#x02013;<lpage>17795</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.232975</pub-id><pub-id pub-id-type="pmid">21454644</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunnath-Velayudhan</surname><given-names>S.</given-names></name><name><surname>Davidow</surname><given-names>A. L.</given-names></name><name><surname>Wang</surname><given-names>H. Y.</given-names></name><name><surname>Molina</surname><given-names>D. M.</given-names></name><name><surname>Huynh</surname><given-names>V. T.</given-names></name><name><surname>Salamon</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients</article-title>. <source>J. Infect. Dis.</source>
<volume>206</volume>, <fpage>697</fpage>&#x02013;<lpage>705</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis421</pub-id><pub-id pub-id-type="pmid">22732925</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunnath-Velayudhan</surname><given-names>S.</given-names></name><name><surname>Salamon</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>H. Y.</given-names></name><name><surname>Davidow</surname><given-names>A. L.</given-names></name><name><surname>Molina</surname><given-names>D. M.</given-names></name><name><surname>Huynh</surname><given-names>V. T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Dynamic antibody responses to the Mycobacterium tuberculosis proteome</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>107</volume>, <fpage>14703</fpage>&#x02013;<lpage>14708</lpage><pub-id pub-id-type="doi">10.1073/pnas.1009080107</pub-id><pub-id pub-id-type="pmid">20668240</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampropoulou</surname><given-names>V.</given-names></name><name><surname>Hoehlig</surname><given-names>K.</given-names></name><name><surname>Roch</surname><given-names>T.</given-names></name><name><surname>Neves</surname><given-names>P.</given-names></name><name><surname>Calderon Gomez</surname><given-names>E.</given-names></name><name><surname>Sweenie</surname><given-names>C. H.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>TLR-activated B cells suppress T cell-mediated autoimmunity</article-title>. <source>J. Immunol.</source>
<volume>180</volume>, <fpage>4763</fpage>&#x02013;<lpage>4773</lpage><pub-id pub-id-type="pmid">18354200</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>T.</given-names></name><name><surname>Natoli</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Transcriptional regulation of macrophage polarization: enabling diversity with identity</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>11</volume>, <fpage>750</fpage>&#x02013;<lpage>761</lpage><pub-id pub-id-type="doi">10.1038/nri3088</pub-id><pub-id pub-id-type="pmid">22025054</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Dial</surname><given-names>S. M.</given-names></name><name><surname>Schmelz</surname><given-names>M.</given-names></name><name><surname>Rennels</surname><given-names>M. A.</given-names></name><name><surname>Ampel</surname><given-names>N. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis</article-title>. <source>Infect. Immun.</source>
<volume>73</volume>, <fpage>3923</fpage>&#x02013;<lpage>3928</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.8.5065-5073.2005</pub-id><pub-id pub-id-type="pmid">15972478</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>F. E.</given-names></name><name><surname>Randall</surname><given-names>T. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Effector and regulatory B cells: modulators of CD4(+) T cell immunity</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>10</volume>, <fpage>236</fpage>&#x02013;<lpage>247</lpage><pub-id pub-id-type="doi">10.1038/nri2729</pub-id><pub-id pub-id-type="pmid">20224569</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglione</surname><given-names>P. J.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>How B cells shape the immune response against Mycobacterium tuberculosis</article-title>. <source>Eur. J. Immunol.</source>
<volume>39</volume>, <fpage>676</fpage>&#x02013;<lpage>686</lpage><pub-id pub-id-type="doi">10.1002/eji.200839148</pub-id><pub-id pub-id-type="pmid">19283721</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglione</surname><given-names>P. J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Casadevall</surname><given-names>A.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection</article-title>. <source>J. Immunol.</source>
<volume>180</volume>, <fpage>3329</fpage>&#x02013;<lpage>3338</lpage><pub-id pub-id-type="pmid">18292558</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglione</surname><given-names>P. J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis</article-title>. <source>J. Immunol.</source>
<volume>178</volume>, <fpage>7222</fpage>&#x02013;<lpage>7234</lpage><pub-id pub-id-type="pmid">17513771</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>S.</given-names></name><name><surname>Dkhar</surname><given-names>H. K.</given-names></name><name><surname>Chandra</surname><given-names>V.</given-names></name><name><surname>Dave</surname><given-names>S.</given-names></name><name><surname>Nanduri</surname><given-names>R.</given-names></name><name><surname>Janmeja</surname><given-names>A. K.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPARgamma and TR4 for survival</article-title>. <source>J. Immunol.</source>
<volume>188</volume>, <fpage>5593</fpage>&#x02013;<lpage>5603</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1103038</pub-id><pub-id pub-id-type="pmid">22544925</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>A.</given-names></name><name><surname>Sica</surname><given-names>A.</given-names></name><name><surname>Sozzani</surname><given-names>S.</given-names></name><name><surname>Allavena</surname><given-names>P.</given-names></name><name><surname>Vecchi</surname><given-names>A.</given-names></name><name><surname>Locati</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>The chemokine system in diverse forms of macrophage activation and polarization</article-title>. <source>Trends Immunol.</source>
<volume>25</volume>, <fpage>677</fpage>&#x02013;<lpage>686</lpage><pub-id pub-id-type="doi">10.1016/j.it.2004.09.015</pub-id><pub-id pub-id-type="pmid">15530839</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>F. O.</given-names></name><name><surname>Helming</surname><given-names>L.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Alternative activation of macrophages: an immunologic functional perspective</article-title>. <source>Annu. Rev. Immunol.</source>
<volume>27</volume>, <fpage>451</fpage>&#x02013;<lpage>483</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132532</pub-id><pub-id pub-id-type="pmid">19105661</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastroeni</surname><given-names>P.</given-names></name><name><surname>Simmons</surname><given-names>C.</given-names></name><name><surname>Fowler</surname><given-names>R.</given-names></name><name><surname>Hormaeche</surname><given-names>C. E.</given-names></name><name><surname>Dougan</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens</article-title>. <source>Infect. Immun.</source>
<volume>68</volume>, <fpage>46</fpage>&#x02013;<lpage>53</lpage><pub-id pub-id-type="doi">10.1128/IAI.68.1.46-53.2000</pub-id><pub-id pub-id-type="pmid">10603367</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R.</given-names></name><name><surname>Schneider</surname><given-names>D. S.</given-names></name><name><surname>Soares</surname><given-names>M. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Disease tolerance as a defense strategy</article-title>. <source>Science</source>
<volume>335</volume>, <fpage>936</fpage>&#x02013;<lpage>941</lpage><pub-id pub-id-type="doi">10.1126/science.1214935</pub-id><pub-id pub-id-type="pmid">22363001</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>S.</given-names></name><name><surname>Alnabulsi</surname><given-names>A.</given-names></name><name><surname>Secombes</surname><given-names>C. J.</given-names></name><name><surname>Bird</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Identification and characterization of the transcription factors involved in T-cell development, t-bet, stat6 and foxp3, within the zebrafish, Danio rerio</article-title>. <source>FEBS J.</source>
<volume>277</volume>, <fpage>128</fpage>&#x02013;<lpage>147</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07460.x</pub-id><pub-id pub-id-type="pmid">19961539</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittrucker</surname><given-names>H. W.</given-names></name><name><surname>Raupach</surname><given-names>B.</given-names></name><name><surname>Kohler</surname><given-names>A.</given-names></name><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection</article-title>. <source>J. Immunol.</source>
<volume>164</volume>, <fpage>1648</fpage>&#x02013;<lpage>1652</lpage><pub-id pub-id-type="pmid">10657605</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moller</surname><given-names>M.</given-names></name><name><surname>Nebel</surname><given-names>A.</given-names></name><name><surname>Valentonyte</surname><given-names>R.</given-names></name><name><surname>Van Helden</surname><given-names>P. D.</given-names></name><name><surname>Schreiber</surname><given-names>S.</given-names></name><name><surname>Hoal</surname><given-names>E. G.</given-names></name></person-group> (<year>2009</year>). <article-title>Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population</article-title>. <source>Tuberculosis</source>
<volume>89</volume>, <fpage>189</fpage>&#x02013;<lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2008.10.001</pub-id><pub-id pub-id-type="pmid">19147409</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>J. W.</given-names></name><name><surname>Beattie</surname><given-names>L.</given-names></name><name><surname>Dalton</surname><given-names>J. E.</given-names></name><name><surname>Owens</surname><given-names>B. M.</given-names></name><name><surname>Maroof</surname><given-names>A.</given-names></name><name><surname>Coles</surname><given-names>M. C.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<fpage>e34143</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0034143</pub-id><pub-id pub-id-type="pmid">22479545</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moseman</surname><given-names>E. A.</given-names></name><name><surname>Iannacone</surname><given-names>M.</given-names></name><name><surname>Bosurgi</surname><given-names>L.</given-names></name><name><surname>Tonti</surname><given-names>E.</given-names></name><name><surname>Chevrier</surname><given-names>N.</given-names></name><name><surname>Tumanov</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity</article-title>. <source>Immunity</source>
<volume>36</volume>, <fpage>415</fpage>&#x02013;<lpage>426</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.01.013</pub-id><pub-id pub-id-type="pmid">22386268</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munder</surname><given-names>M.</given-names></name><name><surname>Eichmann</surname><given-names>K.</given-names></name><name><surname>Modolell</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype</article-title>. <source>J. Immunol.</source>
<volume>160</volume>, <fpage>5347</fpage>&#x02013;<lpage>5354</lpage><pub-id pub-id-type="pmid">9605134</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>Wynn</surname><given-names>T. A.</given-names></name></person-group> (<year>2011a</year>). <article-title>Obstacles and opportunities for understanding macrophage polarization</article-title>. <source>J. Leukoc. Biol.</source>
<volume>89</volume>, <fpage>557</fpage>&#x02013;<lpage>563</lpage><pub-id pub-id-type="doi">10.1189/jlb.0710409</pub-id><pub-id pub-id-type="pmid">21248152</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>Wynn</surname><given-names>T. A.</given-names></name></person-group> (<year>2011b</year>). <article-title>Protective and pathogenic functions of macrophage subsets</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>11</volume>, <fpage>723</fpage>&#x02013;<lpage>737</lpage><pub-id pub-id-type="doi">10.1038/nri3073</pub-id><pub-id pub-id-type="pmid">21997792</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>P.</given-names></name><name><surname>Lampropoulou</surname><given-names>V.</given-names></name><name><surname>Calderon-Gomez</surname><given-names>E.</given-names></name><name><surname>Roch</surname><given-names>T.</given-names></name><name><surname>Stervbo</surname><given-names>U.</given-names></name><name><surname>Shen</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection</article-title>. <source>Immunity</source>
<volume>33</volume>, <fpage>777</fpage>&#x02013;<lpage>790</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.016</pub-id><pub-id pub-id-type="pmid">21093317</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>S.</given-names></name><name><surname>Bonecini-Almeida Mda</surname><given-names>G.</given-names></name><name><surname>Lapa e Silva</surname><given-names>J. R.</given-names></name><name><surname>Nathan</surname><given-names>C.</given-names></name><name><surname>Xie</surname><given-names>Q. W.</given-names></name><name><surname>Mumford</surname><given-names>R.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis</article-title>. <source>J. Exp. Med.</source>
<volume>183</volume>, <fpage>2293</fpage>&#x02013;<lpage>2302</lpage><pub-id pub-id-type="doi">10.1084/jem.183.5.2293</pub-id><pub-id pub-id-type="pmid">8642338</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name><name><surname>Stapleton</surname><given-names>G.</given-names></name><name><surname>Dhar</surname><given-names>V.</given-names></name><name><surname>Pearce</surname><given-names>M.</given-names></name><name><surname>Schumacher</surname><given-names>J.</given-names></name><name><surname>Rugo</surname><given-names>H.</given-names></name><etal/></person-group> (<year>1990</year>). <article-title>Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10</article-title>. <source>Int. Immunol.</source>
<volume>2</volume>, <fpage>821</fpage>&#x02013;<lpage>832</lpage><pub-id pub-id-type="doi">10.1093/intimm/2.9.821</pub-id><pub-id pub-id-type="pmid">1703785</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto Yoshida</surname><given-names>Y.</given-names></name><name><surname>Umemura</surname><given-names>M.</given-names></name><name><surname>Yahagi</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>R. L.</given-names></name><name><surname>Ikuta</surname><given-names>K.</given-names></name><name><surname>Kishihara</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung</article-title>. <source>J. Immunol.</source>
<volume>184</volume>, <fpage>4414</fpage>&#x02013;<lpage>4422</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903332</pub-id><pub-id pub-id-type="pmid">20212094</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A. K.</given-names></name><name><surname>Sassetti</surname><given-names>C. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Mycobacterial persistence requires the utilization of host cholesterol</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>105</volume>, <fpage>4376</fpage>&#x02013;<lpage>4380</lpage><pub-id pub-id-type="doi">10.1073/pnas.0711363105</pub-id><pub-id pub-id-type="pmid">18334639</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pessanha</surname><given-names>A. P.</given-names></name><name><surname>Martins</surname><given-names>R. A.</given-names></name><name><surname>Mattos-Guaraldi</surname><given-names>A. L.</given-names></name><name><surname>Vianna</surname><given-names>A.</given-names></name><name><surname>Moreira</surname><given-names>L. O.</given-names></name></person-group> (<year>2012</year>). <article-title>Arginase-1 expression in granulomas of tuberculosis patients</article-title>. <source>FEMS Immunol. Med. Microbiol.</source>
<volume>66</volume>, <fpage>265</fpage>&#x02013;<lpage>268</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2012.01012.x</pub-id><pub-id pub-id-type="pmid">22827286</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyron</surname><given-names>P.</given-names></name><name><surname>Vaubourgeix</surname><given-names>J.</given-names></name><name><surname>Poquet</surname><given-names>Y.</given-names></name><name><surname>Levillain</surname><given-names>F.</given-names></name><name><surname>Botanch</surname><given-names>C.</given-names></name><name><surname>Bardou</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Foamy macrophages from tuberculous patients&#x02019; granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence</article-title>. <source>PLoS Pathog.</source>
<volume>4</volume>:<fpage>e1000204</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000204</pub-id><pub-id pub-id-type="pmid">19002241</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philips</surname><given-names>J. A.</given-names></name><name><surname>Ernst</surname><given-names>J. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Tuberculosis pathogenesis and immunity</article-title>. <source>Annu. Rev. Pathol.</source>
<volume>7</volume>, <fpage>353</fpage>&#x02013;<lpage>384</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132458</pub-id><pub-id pub-id-type="pmid">22054143</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phuah</surname><given-names>J. Y.</given-names></name><name><surname>Mattila</surname><given-names>J. T.</given-names></name><name><surname>Lin</surname><given-names>P. L.</given-names></name><name><surname>Flynn</surname><given-names>J. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis</article-title>. <source>Am. J. Pathol.</source>
<volume>181</volume>, <fpage>508</fpage>&#x02013;<lpage>514</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.05.009</pub-id><pub-id pub-id-type="pmid">22721647</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popi</surname><given-names>A. F.</given-names></name><name><surname>Godoy</surname><given-names>L. C.</given-names></name><name><surname>Xander</surname><given-names>P.</given-names></name><name><surname>Lopes</surname><given-names>J. D.</given-names></name><name><surname>Mariano</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>B-1 cells facilitate Paracoccidioides brasiliensis infection in mice via IL-10 secretion</article-title>. <source>Microbes Infect.</source>
<volume>10</volume>, <fpage>817</fpage>&#x02013;<lpage>824</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2008.04.012</pub-id><pub-id pub-id-type="pmid">18555722</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qualls</surname><given-names>J. E.</given-names></name><name><surname>Neale</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name><name><surname>Koo</surname><given-names>M. S.</given-names></name><name><surname>Defreitas</surname><given-names>A. A.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling</article-title>. <source>Sci. Signal.</source>
<volume>3</volume>, <fpage>ra62</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2000955</pub-id><pub-id pub-id-type="pmid">20716764</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qualls</surname><given-names>J. E.</given-names></name><name><surname>Subramanian</surname><given-names>C.</given-names></name><name><surname>Rafi</surname><given-names>W.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name><name><surname>Balouzian</surname><given-names>L.</given-names></name><name><surname>Defreitas</surname><given-names>A. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1</article-title>. <source>Cell Host Microbe</source>
<volume>12</volume>, <fpage>313</fpage>&#x02013;<lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.07.012</pub-id><pub-id pub-id-type="pmid">22980328</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana-Murci</surname><given-names>L.</given-names></name><name><surname>Alcais</surname><given-names>A.</given-names></name><name><surname>Abel</surname><given-names>L.</given-names></name><name><surname>Casanova</surname><given-names>J. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases</article-title>. <source>Nat. Immunol.</source>
<volume>8</volume>, <fpage>1165</fpage>&#x02013;<lpage>1171</lpage><pub-id pub-id-type="doi">10.1038/ni1535</pub-id><pub-id pub-id-type="pmid">17952041</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raju</surname><given-names>B.</given-names></name><name><surname>Hoshino</surname><given-names>Y.</given-names></name><name><surname>Belitskaya-Levy</surname><given-names>I.</given-names></name><name><surname>Dawson</surname><given-names>R.</given-names></name><name><surname>Ress</surname><given-names>S.</given-names></name><name><surname>Gold</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Gene expression profiles of bronchoalveolar cells in pulmonary TB</article-title>. <source>Tuberculosis (Edinb.)</source>
<volume>88</volume>, <fpage>39</fpage>&#x02013;<lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2007.07.003</pub-id><pub-id pub-id-type="pmid">17921069</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Revisiting the role of the granuloma in tuberculosis</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>12</volume>, <fpage>352</fpage>&#x02013;<lpage>366</lpage><pub-id pub-id-type="pmid">22517424</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawlings</surname><given-names>D. J.</given-names></name><name><surname>Schwartz</surname><given-names>M. A.</given-names></name><name><surname>Jackson</surname><given-names>S. W.</given-names></name><name><surname>Meyer-Bahlburg</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Integration of B cell responses through Toll-like receptors and antigen receptors</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>12</volume>, <fpage>282</fpage>&#x02013;<lpage>294</lpage><pub-id pub-id-type="doi">10.1038/nri3190</pub-id><pub-id pub-id-type="pmid">22421786</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redente</surname><given-names>E. F.</given-names></name><name><surname>Higgins</surname><given-names>D. M.</given-names></name><name><surname>Dwyer-Nield</surname><given-names>L. D.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name><name><surname>Gonzalez-Juarrero</surname><given-names>M.</given-names></name><name><surname>Malkinson</surname><given-names>A. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation</article-title>. <source>J. Leukoc. Biol.</source>
<volume>88</volume>, <fpage>159</fpage>&#x02013;<lpage>168</lpage><pub-id pub-id-type="doi">10.1189/jlb.0609378</pub-id><pub-id pub-id-type="pmid">20360403</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renshaw</surname><given-names>S. A.</given-names></name><name><surname>Trede</surname><given-names>N. S.</given-names></name></person-group> (<year>2012</year>). <article-title>A model 450 million years in the making: zebrafish and vertebrate immunity</article-title>. <source>Dis. Model Mech.</source>
<volume>5</volume>, <fpage>38</fpage>&#x02013;<lpage>47</lpage><pub-id pub-id-type="doi">10.1242/dmm.007138</pub-id><pub-id pub-id-type="pmid">22228790</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronet</surname><given-names>C.</given-names></name><name><surname>Hauyon-La Torre</surname><given-names>Y.</given-names></name><name><surname>Revaz-Breton</surname><given-names>M.</given-names></name><name><surname>Mastelic</surname><given-names>B.</given-names></name><name><surname>Tacchini-Cottier</surname><given-names>F.</given-names></name><name><surname>Louis</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production</article-title>. <source>J. Immunol.</source>
<volume>184</volume>, <fpage>886</fpage>&#x02013;<lpage>894</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901114</pub-id><pub-id pub-id-type="pmid">19966209</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>E.</given-names></name><name><surname>Stavropoulos</surname><given-names>E.</given-names></name><name><surname>Brennan</surname><given-names>J.</given-names></name><name><surname>Coade</surname><given-names>S.</given-names></name><name><surname>Grigorieva</surname><given-names>E.</given-names></name><name><surname>Walker</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice</article-title>. <source>Infect. Immun.</source>
<volume>73</volume>, <fpage>6101</fpage>&#x02013;<lpage>6109</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.4.2452-2460.2005</pub-id><pub-id pub-id-type="pmid">16113331</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>D. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Who puts the tubercle in tuberculosis?</article-title>
<source>Nat. Rev. Microbiol.</source>
<volume>5</volume>, <fpage>39</fpage>&#x02013;<lpage>47</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1538</pub-id><pub-id pub-id-type="pmid">17160001</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>D. G.</given-names></name><name><surname>Cardona</surname><given-names>P. J.</given-names></name><name><surname>Kim</surname><given-names>M. J.</given-names></name><name><surname>Allain</surname><given-names>S.</given-names></name><name><surname>Altare</surname><given-names>F.</given-names></name></person-group> (<year>2009</year>). <article-title>Foamy macrophages and the progression of the human tuberculosis granuloma</article-title>. <source>Nat. Immunol.</source>
<volume>10</volume>, <fpage>943</fpage>&#x02013;<lpage>948</lpage><pub-id pub-id-type="doi">10.1038/ni.1781</pub-id><pub-id pub-id-type="pmid">19692995</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>R. T.</given-names></name><name><surname>Mariano</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>B-1 cell protective role in murine primary Mycobacterium bovis bacillus Calmette-Guerin infection</article-title>. <source>Immunobiology</source>
<volume>215</volume>, <fpage>1005</fpage>&#x02013;<lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2010.01.003</pub-id><pub-id pub-id-type="pmid">20188435</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakula</surname><given-names>A.</given-names></name></person-group> (<year>1982</year>). <article-title>Robert Koch: centenary of the discovery of the tubercle bacillus, 1882</article-title>. <source>Thorax</source>
<volume>37</volume>, <fpage>246</fpage>&#x02013;<lpage>251</lpage><pub-id pub-id-type="doi">10.1136/thx.37.4.246</pub-id><pub-id pub-id-type="pmid">6180494</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schebesch</surname><given-names>C.</given-names></name><name><surname>Kodelja</surname><given-names>V.</given-names></name><name><surname>Muller</surname><given-names>C.</given-names></name><name><surname>Hakij</surname><given-names>N.</given-names></name><name><surname>Bisson</surname><given-names>S.</given-names></name><name><surname>Orfanos</surname><given-names>C. E.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro</article-title>. <source>Immunology</source>
<volume>92</volume>, <fpage>478</fpage>&#x02013;<lpage>486</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2567.1997.00371.x</pub-id><pub-id pub-id-type="pmid">9497489</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schon</surname><given-names>T.</given-names></name><name><surname>Elmberger</surname><given-names>G.</given-names></name><name><surname>Negesse</surname><given-names>Y.</given-names></name><name><surname>Pando</surname><given-names>R. H.</given-names></name><name><surname>Sundqvist</surname><given-names>T.</given-names></name><name><surname>Britton</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Local production of nitric oxide in patients with tuberculosis</article-title>. <source>Int. J. Tuberc. Lung Dis.</source>
<volume>8</volume>, <fpage>1134</fpage>&#x02013;<lpage>1137</lpage><pub-id pub-id-type="pmid">15455601</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>T.</given-names></name><name><surname>Ehlers</surname><given-names>S.</given-names></name><name><surname>Heitmann</surname><given-names>L.</given-names></name><name><surname>Rausch</surname><given-names>A.</given-names></name><name><surname>Mages</surname><given-names>J.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity</article-title>. <source>J. Immunol.</source>
<volume>183</volume>, <fpage>1301</fpage>&#x02013;<lpage>1312</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0803567</pub-id><pub-id pub-id-type="pmid">19561100</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shearer</surname><given-names>J. D.</given-names></name><name><surname>Richards</surname><given-names>J. R.</given-names></name><name><surname>Mills</surname><given-names>C. D.</given-names></name><name><surname>Caldwell</surname><given-names>M. D.</given-names></name></person-group> (<year>1997</year>). <article-title>Differential regulation of macrophage arginine metabolism: a proposed role in wound healing</article-title>. <source>Am. J. Physiol.</source>
<volume>272</volume>, <fpage>E181</fpage>&#x02013;<lpage>E190</lpage><pub-id pub-id-type="pmid">9124321</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sica</surname><given-names>A.</given-names></name><name><surname>Larghi</surname><given-names>P.</given-names></name><name><surname>Mancino</surname><given-names>A.</given-names></name><name><surname>Rubino</surname><given-names>L.</given-names></name><name><surname>Porta</surname><given-names>C.</given-names></name><name><surname>Totaro</surname><given-names>M. G.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Macrophage polarization in tumour progression</article-title>. <source>Semin. Cancer Biol.</source>
<volume>18</volume>, <fpage>349</fpage>&#x02013;<lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2008.03.004</pub-id><pub-id pub-id-type="pmid">18467122</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smelt</surname><given-names>S. C.</given-names></name><name><surname>Cotterell</surname><given-names>S. E.</given-names></name><name><surname>Engwerda</surname><given-names>C. R.</given-names></name><name><surname>Kaye</surname><given-names>P. M.</given-names></name></person-group> (<year>2000</year>). <article-title>B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology</article-title>. <source>J. Immunol.</source>
<volume>164</volume>, <fpage>3681</fpage>&#x02013;<lpage>3688</lpage><pub-id pub-id-type="pmid">10725726</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tjarnlund</surname><given-names>A.</given-names></name><name><surname>Rodriguez</surname><given-names>A.</given-names></name><name><surname>Cardona</surname><given-names>P. J.</given-names></name><name><surname>Guirado</surname><given-names>E.</given-names></name><name><surname>Ivanyi</surname><given-names>J.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice</article-title>. <source>Int. Immunol.</source>
<volume>18</volume>, <fpage>807</fpage>&#x02013;<lpage>816</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxl017</pub-id><pub-id pub-id-type="pmid">16569672</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrado</surname><given-names>E.</given-names></name><name><surname>Cooper</surname><given-names>A. M.</given-names></name></person-group> (<year>2011</year>). <article-title>What do we really know about how CD4 T cells control Mycobacterium tuberculosis?</article-title>
<source>PLoS Pathog.</source>
<volume>7</volume>:<fpage>e1002196</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002196</pub-id><pub-id pub-id-type="pmid">21829359</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>M. C.</given-names></name><name><surname>Chakravarty</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Koch</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension</article-title>. <source>Cell. Microbiol.</source>
<volume>8</volume>, <fpage>218</fpage>&#x02013;<lpage>232</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00612.x</pub-id><pub-id pub-id-type="pmid">16441433</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrichs</surname><given-names>T.</given-names></name><name><surname>Kosmiadi</surname><given-names>G. A.</given-names></name><name><surname>Trusov</surname><given-names>V.</given-names></name><name><surname>Jorg</surname><given-names>S.</given-names></name><name><surname>Pradl</surname><given-names>L.</given-names></name><name><surname>Titukhina</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung</article-title>. <source>J. Pathol.</source>
<volume>204</volume>, <fpage>217</fpage>&#x02013;<lpage>228</lpage><pub-id pub-id-type="doi">10.1002/path.1628</pub-id><pub-id pub-id-type="pmid">15376257</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermi</surname><given-names>W.</given-names></name><name><surname>Facchetti</surname><given-names>F.</given-names></name><name><surname>Riboldi</surname><given-names>E.</given-names></name><name><surname>Heine</surname><given-names>H.</given-names></name><name><surname>Scutera</surname><given-names>S.</given-names></name><name><surname>Stornello</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma</article-title>. <source>Blood</source>
<volume>107</volume>, <fpage>454</fpage>&#x02013;<lpage>462</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-04-1342</pub-id><pub-id pub-id-type="pmid">16189275</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkman</surname><given-names>H. E.</given-names></name><name><surname>Clay</surname><given-names>H.</given-names></name><name><surname>Beery</surname><given-names>D.</given-names></name><name><surname>Chang</surname><given-names>J. C.</given-names></name><name><surname>Sherman</surname><given-names>D. R.</given-names></name><name><surname>Ramakrishnan</surname><given-names>L.</given-names></name></person-group> (<year>2004</year>). <article-title>Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant</article-title>. <source>PLoS Biol.</source>
<volume>2</volume>:<fpage>e367</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0020367</pub-id><pub-id pub-id-type="pmid">15510227</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkman</surname><given-names>H. E.</given-names></name><name><surname>Pozos</surname><given-names>T. C.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Rawls</surname><given-names>J. F.</given-names></name><name><surname>Ramakrishnan</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium</article-title>. <source>Science</source>
<volume>327</volume>, <fpage>466</fpage>&#x02013;<lpage>469</lpage><pub-id pub-id-type="doi">10.1126/science.1179663</pub-id><pub-id pub-id-type="pmid">20007864</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voswinkel</surname><given-names>J.</given-names></name><name><surname>Assmann</surname><given-names>G.</given-names></name><name><surname>Held</surname><given-names>G.</given-names></name><name><surname>Pitann</surname><given-names>S.</given-names></name><name><surname>Gross</surname><given-names>W. L.</given-names></name><name><surname>Holl-Ulrich</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Single cell analysis of B lymphocytes from Wegener&#x02019;s granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions</article-title>. <source>Clin. Exp. Immunol.</source>
<volume>154</volume>, <fpage>339</fpage>&#x02013;<lpage>345</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03775.x</pub-id><pub-id pub-id-type="pmid">18826496</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winthrop</surname><given-names>K. L.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name><name><surname>Beekmann</surname><given-names>S. E.</given-names></name><name><surname>Polgreen</surname><given-names>P. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network</article-title>. <source>Clin. Infect. Dis.</source>
<volume>46</volume>, <fpage>1738</fpage>&#x02013;<lpage>1740</lpage><pub-id pub-id-type="doi">10.1086/587989</pub-id><pub-id pub-id-type="pmid">18419421</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittamer</surname><given-names>V.</given-names></name><name><surname>Bertrand</surname><given-names>J. Y.</given-names></name><name><surname>Gutschow</surname><given-names>P. W.</given-names></name><name><surname>Traver</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Characterization of the mononuclear phagocyte system in zebrafish</article-title>. <source>Blood</source>
<volume>117</volume>, <fpage>7126</fpage>&#x02013;<lpage>7135</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-11-321448</pub-id><pub-id pub-id-type="pmid">21406720</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojciechowski</surname><given-names>W.</given-names></name><name><surname>Harris</surname><given-names>D. P.</given-names></name><name><surname>Sprague</surname><given-names>F.</given-names></name><name><surname>Mousseau</surname><given-names>B.</given-names></name><name><surname>Makris</surname><given-names>M.</given-names></name><name><surname>Kusser</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus</article-title>. <source>Immunity</source>
<volume>30</volume>, <fpage>421</fpage>&#x02013;<lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.01.006</pub-id><pub-id pub-id-type="pmid">19249230</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. C.</given-names></name><name><surname>Puaux</surname><given-names>A. L.</given-names></name><name><surname>Chittezhath</surname><given-names>M.</given-names></name><name><surname>Shalova</surname><given-names>I.</given-names></name><name><surname>Kajiji</surname><given-names>T. S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Macrophage polarization to a unique phenotype driven by B cells</article-title>. <source>Eur. J. Immunol.</source>
<volume>40</volume>, <fpage>2296</fpage>&#x02013;<lpage>2307</lpage><pub-id pub-id-type="doi">10.1002/eji.200940288</pub-id><pub-id pub-id-type="pmid">20468007</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Q. W.</given-names></name><name><surname>Nathan</surname><given-names>C.</given-names></name></person-group> (<year>1993</year>). <article-title>Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-gamma and bacterial lipopolysaccharide</article-title>. <source>Trans. Assoc. Am. Physicians</source>
<volume>106</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage><pub-id pub-id-type="pmid">7518621</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Graner</surname><given-names>M. W.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Liao</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>B cell infiltration is associated with the increased IL-17 and IL-22 expression in the lungs of patients with tuberculosis</article-title>. <source>Cell. Immunol.</source>
<volume>270</volume>, <fpage>217</fpage>&#x02013;<lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2011.05.009</pub-id><pub-id pub-id-type="pmid">21741035</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses</article-title>. <source>Cell. Immunol.</source>
<volume>274</volume>, <fpage>89</fpage>&#x02013;<lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2012.01.007</pub-id><pub-id pub-id-type="pmid">22361174</pub-id></mixed-citation></ref></ref-list></back></article>